Podcasts about mitigating

We're hitting "replay" and raising a mug of cocoa! ☕️

Today, we explore why heart attack deaths peak during the last week of December. We also learn how to enjoy the holiday season with pets ready for adoption. Plus, a local architecture studio receives a prestigious award. 

This week, Angela discusses charitable giving and how individuals can maximize their donations to causes they care about while also benefiting themselves from a tax perspective. She emphasizes the importance of asking questions and seeking holistic financial planning to understand how to give more effectively. Key Takeaways

John F. Banghart, Senior Director for Cybersecurity Services, Venable LLP, speaks with Errol S. Weiss, Chief Security Officer, Health-ISAC, Inc., about the unique challenges associated with information sharing in the health care sector. They discuss what an ISAC is; what information sharing means in the context of the health care sector and why it is important; legal, regulatory, and compliance risks; risk mitigation strategies; the impact of the Cybersecurity Information Sharing Act of 2015; and how to facilitate cooperation in information sharing among various stakeholders. Sponsored by Venable.Watch this episode: https://www.youtube.com/watch?v=2sRx96w1U70Learn more about Venable: https://www.venable.com/ Essential Legal Updates, Now in Audio AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast. Stay At the Forefront of Health Legal Education Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.

Drs. Jack Cush and Artie Kavanaugh preview the upcoming RNL 2026 meeting in Dallas, TX on February 7 & 8, 2026. Register at RheumNow.Live Below is the program: Saturday, February 7, 2026, 7:50 - 8:00 am Welcome & Introductions Drs. Cush and Kavanaugh 8:00 - 10:00 am POD I - Rheumatoid Arthritis: Achieving Better Outcomes 8:00 – 8:30 am Mortality in RA: A Story of Decline, Delay, or Plateau? Elena Myasoedova, MD 8:30 – 9:00 am The Mucosal Hypothesis of Rheumatoid Arthritis Kristen Demoruelle, MD 9:00 – 9:30 am ILD in RA – Recent Advances Jeffrey Sparks, MD 9:30 – 10:00 am Rheumatoid arthritis Faculty Q&A 10:00 - 10:15 am STEP 1: Placebos in Rheumatology Andreas Kerschbaumer, MD 10:15 -10:30 am STEP 2: Disease Modification in Osteoarthritis Tuhina Neogi, MD PhD 10:30 – 11:05 Break 11:05 - 12:10 pm POD II – Advancing Practice 11:05 – 11:30 am Obesity & Inflammation: Weight Management in Rheumatology Uzma Haque, MD 11:30 - 11:55 am Mitigating risk in Rheum Pts undergoing surgery Susan Goodman, MD 11:55 -12:10 pm Practice Panel Faculty Q&A 12:10 – 1:00pm Lunch 1:00 – 3:00 pm POD III – Decisions in Psoriatic Arthritis 1:00 - 1:30 pm Paradoxical Psoriasis and Strange Reactions Joseph Merola, MD 1:30 - 2:00 pm Why Do Plain X rays in Psoriatic Arthritis Arthur Kavanaugh, MD 2:00 - 2:30 pm IL-23 vs IL-17 inhibitors in PsA Andre Ribero, MD 2:30 - 3:00 pm Past, Present & Future of Gout Robert Terkeltaub, MD 3:00 - 3:30 pm Psoriatic Faculty Q&A 3:30 - 4:05 pm Break 4:05 - 4:20 pm STEP 3: Helicobacter Pylori update Byron Cryer, MD 4:20 - 4:35 pm STEP 4: History of Gout Robert Terkeltaub, MD 4:35 – 5:15 pm Keynote Address: 50 Years of Osteoporosis Michael McClung, MD 5:30 – 7:00 pm Reception Sunday, February 8, 2026 Day TOPIC Speaker 7:50-8:00 am Welcome & Introductions Drs. Cush and Kavanaugh 8:00 - 10:00 am POD IV – Staying Ahead of Spondyloarthritis 8:00 – 8:30 am Diagnosing Axial Spondyloarthritis in 2026 Denis Poddubnyy, MD 8:30 – 9:00 am Spondyloarthritis Complications Jessica Walsh, MD 9:00 – 9:30 am 2026 Advances in Spondyloarthritis Catherine Bakewell, MD 9:30 – 10:00 am Spondyloarthritis Faculty Q&A 10:00 – 10:15 am STEP 5: Asymptomatic Elevation of CK Rojit Agarwal, MD MS 10:15 – 10:30 am STEP 6: Update on Myositis Antibodies Rojit Agarwal, MD MS 10:30 – 11:05 am Break 11:05 – 12:10 am POD V – Highlights in Autoimmune Disease 11:05 - 11:35 am SMILE Study – Hydroxychloroquine in ANA+ Arthralgia Nancy Olsen, MD 11:35 – 12:05 am Sjogren's Treatment Landscape in 2026 Matthew Baker, MD 12:05 - 12:20 pm Autoimmune Faculty Q&A 12:20 – 1:25 pm POD VI - Large & Small Vessel Vasculitis 12:20 – 12:45 pm Embracing Relapses in PMR and GCA Michael Putman, MD 12:45 - 1:10 pm Small vessel vasculitis Clay Cockerell, MD 1:10 - 1:25 pm Vasculitis Faculty Q&A 1:30 pm Adjourn

Jennifer Keeley and Mary Whittenhall, experienced nurse practitioners in the field of pulmonary hypertension, discuss the management of cough in patients receiving inhaled therapies for pulmonary hypertension and interstitial lung disease. #GossamerBioPartner #sponsored This Special Edition episode is sponsored by Gossamer Bio. Jennifer Keeley, DPN: My name's Jennifer Keeley. I'm a nurse practitioner and I practice in a large academic institution in Pittsburgh, Pennsylvania, Allegheny Health Network, specifically Allegheny General Hospital. I am a nurse practitioner there and have been in the clinic over 10 years, and in the PH space as a nurse practitioner for over 15 years, as a registered nurse for almost 20 years. So, I have a lot of experience and I'm really excited to be here today to talk about inhaled therapies and cough. Mary Whittenhall, MSN: My name is Mary Whittenhall. I'm also a nurse practitioner. I am currently an advanced practice provider at Pulmonary and Sleep Associates in East Providence, Rhode Island. I've been in pulmonary hypertension for about 11 years now. In that time, I have worked in a variety of settings, both inpatient and outpatient, managing patients with pulmonary vascular disease, and have also touched upon patients with interstitial lung disease and pulmonary hypertension.  I get very excited when I hear about new opportunities for our PH patients. I think a lot about even when I started in pulmonary hypertension and the therapies that were available to our patients. Many of these therapies had been around for a little bit of time. But also something that I think is extremely exciting is that there's just been a rapid progression in development of therapies. And now, with the focus of looking at these therapies as potentially disease modifying, not necessarily slowing the progression of disease. With the advent of all of these new therapies, there become more options for our patients, as well. Often, patients can't tolerate some of the medications that we have due to side effects and despite lots of work to manage these side effects, the patients are not always successful. One of the great things being involved in an academic center is that we have the ability to help link patients to cutting edge research, particularly looking at a new drug that is an inhaled therapy that has shown significant promise in improving the lives of patients with pulmonary hypertension. As a part of the PH community, we all do quite a bit of networking with each other, as well as with our patients and other colleagues in the space. In that time, we did network regarding the study and have participated in some activities where we're looking at the data from the Phase 2 part of this trial and then also looking at some of the side effect management related to the medication, which seemingly is well tolerated. However, for some patients it may not come extremely easy. I think that's where the role of the nurse or the advanced practice provider really comes in this space is that we have a real strong dedication to helping educate patients about ways to manage these side effects. We want patients to be able to continue with therapies. We don't want them to say, "Well, this isn't working for me, it's time to move on." I think that we have a lot of strategies and a lot of experience with trying to help patients really figure out the best way to manage these things and to be confident that they can continue on with obviously the biggest benefit of improving their pulmonary vascular disease. Jennifer Keeley, DPN: We actually met at an advisory board last year. It was an advisory board consistent of registered nurses and nurse practitioners who, just like Mary and myself, have vast experience with patients and therapies, not just in the inhaled space, but more conventional pulmonary vasodilator medications that have been used in our patients for many, many years. As Mary had suggested before, when we start to think about newer agents, many, many of them are not the conventional pulmonary vasodilator medications, but disease modifying agents. Now, we've acquired an armamentarium of medications. So, inhaled delivery is just a really great option to avoid systemic side effects on top of each other. Our PH patients today, many of them are on more than three therapies, many of them are on four or even more therapies, so the delivery of the medication is just one aspect. When we talk about cough and side effects, I like to think about it and explain to my patient when we talk about side effects, particularly cough, to imagine a Venn diagram with cough being in the middle and what affects cough. You see this outward circle, how we deliver it, what kind of device we deliver it in. The drug, how small, large are the particle size? Is it easy enough to use for our patients? The formulation, is it dry powdered versus inhaled aerosolized? And then finally, just the patient themselves. What's their background? What type of PAH do they have? So, we can talk a little bit more about this, but just to get us started, this is how this developed and we had a lovely advisory board meeting with seralutinib and Gossamer Bio, and this was the outcome of it. We produced a lovely poster. This is a conversation if you will, that Mary and I are going to have based on what we talked about and the poster production, that came out of that wonderful advisory board. Mary Whittenhall, MSN: Inhaled therapies are unique in a way in that they actually have direct access to the lungs. So, when you think of an oral medication, an oral medication needs to be digested in the gut and sometimes that systemic digestion takes a while. Additionally, it's also often that we see patients that have more systemic side effects when we're using an oral formulation. Intravenous or subcutaneous formulations of these medications tend to cause pretty strong systemic side effects for patients, and there tends to be a lot of management that we need to do to help make these side effects more tolerable. For most of our patients, I say to them, "You're going to think I'm cruel because I don't really want these side effects to go away." In a way, we look at them almost as if you have a cup and your cup is full of water and after the top of the water hits the rim of the cup, then the water starts to spill over onto the sides of the cup. I think of other medications that we typically prescribe for patients in that way that when we get that spill over, so to speak, it's an indication that we've actually targeted all of those receptors that we want to help with vasodilation. Now that we're looking at other medications that don't really necessarily look at vasodilation, we're looking more at treating the blood vessels in a different way or affecting the process for which those blood vessels become diseased. I think that the side effects become different and I think they become less. In working with inhaled therapies, as you can imagine, the number one side effect that most patients will complain of is cough. Sometimes we have patients who have an underlying cough already, and that's usually not related to PAH, but in PH-ILD where we now have an FDA indication to use another inhaled therapy, we've seen in treating these patients that baseline cough is something that is extremely problematic for them before they even start therapies. So, trying to find ways to improve that baseline cough, treat any underlying symptoms, things like acid reflux as well, that may cause that, treating seasonal allergies, et cetera, and then, obviously, managing any additional overlapping side effects that may occur because of the new therapy that they're on. Jennifer Keeley, DPN: I think that's a really important part, is to talk with the patient, educate the patient on these inhaled therapies. First and foremost, that cough is almost an expected side effect. These are patients particularly with our interstitial lung disease patients that have PAH, cough is a part of their daily life. It's important to document and ascertain what these patients' baseline cough is. In many, many clinics, particularly pulmonary PAH clinics, and I'm sure much like Mary's, many of my colleagues have recommended using validated cough questionnaires so that we can get a really, really good baseline of what that patient's baseline cough is. Are you coughing at night? Do you have mucus? How long have you been coughing? Does it interfere with the quality of your life? Do you cough at night? Does it keep you up? Does it interrupt your sleep? Those kinds of things that help differentiate acute cough versus chronic cough. Many of these patients cough every day. They also have other inhaled therapies such as our ILD patients that are also on corticosteroids, many of them on inhaled corticosteroid therapy that can thin the oral pharynx, the posterior pharynx, and really affect the degree of nerve innervation in the posterior pharynx in the mouth. So, just really understanding what the patient's baseline cough is and educating them on the fact that cough is likely going to be a side effect with the use of this inhaled therapy. Certainly, as we continue to use the therapy, we would hope that the cough can be mitigated either through some lifestyle modifications, some natural remedies, and even some medical remedies such as bronchodilators. But really teaching the patient about the medication and inherently that this is likely going to induce a cough, but that we have mitigation strategies to help dissipate the cough. I always like to tell my patients also in the clinical trials, particularly the Phase 2 clinical trials that are out there that patients had a lot of cough. The patients on drug that were in most of the Phase 2 clinical trials for seralutinib and even for treprostinil inhaled, 30 to 40% of them experienced cough. But at the same token, the placebo-based patients that did not receive drug in these Phase 2 clinical trials also had a lot of cough. So, what that's telling you is yes, you're going to get probably some more cough, but it's likely not going to be that much or more far advanced than the cough that you're already experiencing. I also think it's important to tell these patients, many, many patients that experienced cough did not stop the medication. Actually, in these Phase 2 clinical trials, very few stop the medication. So, that gives you a really good big picture that we are pretty good at educating our patients how to mitigate cough, and if we aren't, then we should learn how to do so. Mary Whittenhall, MSN: I think it's important for us to set some expectations for patients when we're talking about cough. We've already discussed a bit that cough can happen for people from other things outside of their lung disease, but it's important to also look at what may be causing the cough when we are giving a patient an inhaled therapy. So, any type of inhaled therapy, whether that be a dry powder, a mist, whether that's nebulized or through in actuated inhaler, there are particles inside of that medication as it's going in and those little particles, when your lungs inhale that medication, those particles are penetrating your lungs and your lungs are not accustomed to them being there. It's almost as if your lungs are saying, "I don't recognize this. I don't know why this is here," and it may feel like it's an irritant, so you may start coughing as a result of that, but the cough is not necessarily a bad thing. Those particles are there, and the job is to essentially help deliver the medicine to penetrate that lung tissue and then for your body then to absorb the medicine. Your airways and your blood vessels inside of your lungs are extremely close to each other. So, when you inhale that medication, those little blood vessels are also right next to where those airways are, and then that is how those blood vessels then absorb that medication, because they're so close to the site at which those particles come into your lungs. Jennifer Keeley, DPN: I think this is an important concept to understand. They choose the form of delivery based on the goal of delivering the most medication efficiently to the distal bronchioles. That's where the disease is. It's in the distal arteries. So, trying to formulate how we get these very powerful, oftentimes disease modifying agents into the periphery of the lungs can be very challenging. Dry powdered inhaler is one form that the variability of delivery is not as dispersed as an aerosolized. So, it's more efficient delivery to the place where the medication needs to work the best, and that's in the distal periphery of the lungs. Unfortunately, one thing you have to deal with is that oftentimes these medications, dry powdered medications, not just in the PH space, but there's a lot of other dry powdered inhalers in the COPD space, as well. Oftentimes, what happens is these powdered particles get dispersed extra thoracically. So, they get dispersed in the oral mucosa, in the posterior pharynx, on the way down into the stomach. That's wherein we have to deal with mitigating side effects. The biggest side effect of these particles, even though they're very small, is cough. So, technique comes into play. Mitigating things to coat the posterior pharynx come into play. Re-education comes into play. Show me again how you're doing this inhalation, because I don't think that you're holding this okay. In one instance, I had a patient that was inhaling dry powdered inhaler with the medication right out of the refrigerator. So, the medication was cold. It was clumping at the back of her throat. All of these things really take into consideration how we most efficiently get the medicine to these pulmonary arterial hypertension patients where their disease is oftentimes very difficult to get to, and other forms of medications that are systemic, orals, parenterals that have first pass metabolism, and so you're going to get more side effects from those medications. So, I always teach my patients, "Hey, we're a couple steps ahead because we're bypassing the type of metabolism that you get with orals and even parenterals." Mary Whittenhall, MSN: There are so many challenges that these patients face. Oftentimes, patients have never been sick before they develop this, and now we're putting them on multiple therapies, multiple modalities, telling them that there's going to be side effects and they need to learn how to manage them. It's certainly a lot to handle. But I think one of the best things that we have in our PH community is that we really work so hard to partner with the patients and their loved ones and forming this relationship, fostering that relationship as time goes on, I believe that these patients really do trust us and that what we're telling them is things are going to be okay. We are going to be there by your side. We're not going to give you this medicine and then say, "See you in six months. Hope everything goes well." We're really going to be working with them. In some cases in my specialty clinic, we have nurses, we have a pharmacist, a pharmacy tech, and then our advanced practice providers that check in with these patients quite regularly. We are actually taking the initiative to reach out to them versus the patient who may be having trouble advocating for themselves or feeling like, "Really, I don't want to be a pain, but this is challenging for me." We are really in touch with them, and that connection also helps to keep patients on therapy. So, what are some of the specific techniques to manage or mitigate cough? This is something that was a real hot topic at our last advisory meeting. We put together a bunch of folks in the room who deal with other inhaled therapies and patients that have cough and said, "Well, what do you tell patients to do?" First and foremost is to look at any other potentially underlying conditions that may be causing cough and ensure that treatment of those underlying conditions is optimized. I think cough is actually the number one referral for any type of pulmonary practice, but it is a really, really broad differential when it comes down to it. We obviously look first at things like environmental factors. If this could be seasonal allergies, then we try treating patients with antihistamines. Perhaps some of those are intranasal, as well, that may help with some things like rhinorrhea or post nasal drip. Acid reflux is actually a huge, huge reason for cough. Many patients say, 'Well, I don't get acid reflux. I don't feel that burning in my chest after I eat," but come to find out that it can actually be a silent trigger. So, treating patients with medicines that help to reduce acid or suppress acid will oftentimes help with that cough. On top of that, when we're dealing with patients that are on inhalers and now we're adding another inhaled therapy. I find that for some patients that are on actual inhalers that sometimes they do better with nebulized treatments. The nebulized treatments are slower, and may have a bit of a better penetration into the lungs and the patients tend to like it. It is one of those things that you do need to be compliant with in order to really see the benefits to it. I will say that oftentimes, again, partnering with the patient, giving them specific instructions about how to do all of this, we can really see some improvement to those symptoms. Then, there's just basic over-the counter measures and precautions, things like making sure that when you're eating that you're not laying down at least for 60 minutes after you've been eating. If you do have acid reflux, trying to sleep with two pillows or a wedge pillow, that can help to keep the head of your bed elevated. Some of our patients have those really fancy adjustable beds that are also quite helpful for that. I think that sometimes things like basic cough drops actually can be quite wonderful and helpful. Drinking very cold or very warm water or tea, adding some honey to that if a patient isn't diabetic, things like that tend to really help with cough. We reinforce these measures when we start therapies like this. Jennifer Keeley, DPN: In terms of mitigation, I think it's really important on technique. This is why, as Mary had alluded to, it's so important to follow up closely with these patients, particularly our elderly patients who sometimes don't, if they have connective tissue disease or scleroderma, have a lot of good fine motor coordination. A couple of things that I wanted to touch on with regards to that… One, these inhalers are typically high resistance, low flow. So, these are not the type of patients that need to be taking in very forceful inhalations with these inhalers and thank goodness, because we're talking about patients that have inflammatory interstitial lung disease, as well as pulmonary vascular disease. So their degree of inspiratory effort is actually minimal to disperse that medication to the distal pulmonary bronchials. It's equivalent to them taking a deep breath in when you ask them to auscultate their lungs. So it's not a big forceful breath. The other thing is too, a lot of times, sometimes more variability in the disbursement of the drug is better in compliance with some patients. Dry-powdered inhalers, again, do not take a very big forceful effort, but some of them, because they are powder, some of the medication will actually hit the back of the throat as it goes down and can cause some irritation, whereas the nebulized form does have a variability in disbursement and can be more easily tolerated in some. The other issue is the technique itself. Oftentimes, we ask them in some of the inhaled therapies to lower the device itself so that the tongue doesn't protrude and get in the way, because if medication gets on the tongue, the next swallow that they take, that medication is going to hit their posterior pharynx, and they're going to probably cough pretty aggressively. I always start off by telling my patients, "Cough is not a bad thing. It's actually a protective reflex and it's involuntary. So, if you cough, don't actually negate it. Don't think it's a bad thing." It's actually a very protective mechanism that avoids irritation in most of our patients probably already irritated mucosa. So, that's how I like to start the conversation. There's so many good techniques that we can share with them over time, and I might add that each patient is different. Each patient needs to have a personalized plan. When we talk about giving patients warm tea, typically chamomile, chamomile tea in itself is anti-inflammatory. Then, when you add something like honey, which is also a soothing, anti-inflammatory natural remedy, you have to really think to yourself, "They're getting honey. If they're diabetic, we don't want to give them too much honey." But, you have to make sure that their swallowing technique is good. There's no aspiration there, particularly if we give them cough drops. Then, just simple things that actually numb or anesthetize the back of the throat are very, very helpful for elderly patients who do have very friable tissue and mucosa from previous therapies like inhaled corticosteroids, as I had talked about before. Dairy products, I tend to ask my patients to avoid those. They can produce a lot of mucus, which these coughs that we see in our inhaled therapy patients are typically tend to be dry coughs, but some patients that have concomitant asthma, COPD, along with their ILD that are using these inhaled therapies can actually have more of a congested mucoid cough. So, avoiding dairy before and after use is always very smart. Avoiding alcohol, avoiding acidic drinks like orange juice, also very, very helpful. Mary Whittenhall, MSN: The part about technique I think is so, so important here. Oftentimes, when patients start these therapies, when they are approved in that space, the specialty pharmacy has a nurse educator that will come out to the patient's home and provide education not only about the medication, but about the administration of that medication. In many cases, the patients will take their first dose while the nurse is present so that the nurse can then critique whether or not the patient took it appropriately and how they tolerated it. I'm going to give a shout out to our nurse educators from the specialty pharmacies, because they are also a really crucial set of eyes and ears for us out in the community. They do provide education to the patients in the home. We have had situations where the patient has done well while the nurse is there, and then two weeks later we get a call from the patient saying, "I can't do this. This isn't working for me." And I'll say, "Okay. Well, you have a couple options. We can have you come in to the clinic and I want you to bring your device with you, and I would like to watch you do a treatment, or I can have the nurse come out and see you again and go over that." And they'll say, "I already know what I'm doing. I don't need that." But in many instances, we have found that they have adjusted their technique. They might've gotten into some bad habit since the nurse has left them. So, really reinforcing that is important. The other thing that I wanted to bring up is that some of our patients with connective tissue disease also have thickness in their tongues. So, their tongues become thicker and more sclerotome as their connective tissue disease progresses. For some of those patients, it is actually hard for them to get their tongue flat enough so that they can get the medication down into their lungs. So, working with those patients to find strategies to help rectify that. I will say that it is not impossible, it just takes maybe a little extra work. Jennifer Keeley, DPN: Inhaled therapies in themselves are pretty portable. Mary had alluded to a little bit earlier, our patients with pulmonary vascular disease, PAH, that are on parenteral therapies, delivering the conventional pulmonary vasodilator therapies. As we get into the new disease modifying agents such as seralutinib, which are anti-fibrotic, anti-inflammatory, anti-prolific medications, these are portable therapies that are actually modifying the disease. So they're portable. They're easy to use. They're easy to use for our patients, again, that are elderly or are younger and are still working, they have a professional life, they don't have to wear a pump that's 24/7 oftentimes. They can use these inhaled therapies first to see if they can avoid parenteral therapy with prostacyclins. Their quality of life is improved immensely. When you can take an inhaled therapy two to four times a day and really improve quality of life, decrease cough, decrease dyspnea, or shortness of breath on exertion. Sometimes, these patients that do very, very well can actually reduce their supplemental oxygen needs. Just improving their walk distances without having to stop or have excessive dyspnea, improves their quality of life. More time spent with loved ones and more time spent in social environments rather than sitting at home. These wonderful inhaled portable therapies have significantly changed our patients' lives and improved their quality of lives. Mary Whittenhall, MSN: This community I think is phenomenal. It's made up of so many great people. There are many patients who have been a part of this space for a long time who really want to help other patients who may be newer to the journey than them. I'm a big advocate for support groups. We've had an extremely active support group in our area for a long time, and I often partner some of my patients that have been with me for quite some time with some of the new patients that may need a bit more help. I can tell them things and my colleagues can tell them things. Oftentimes, the same message doesn't resonate. It resonates differently, I think when it comes from a peer, a patient who may have experienced the same thing as them. One of the things that I really try to drive home with our patients is just that sense of empowerment. Connect with these other folks in the community. They want to help you. They remember what it feels like being newly diagnosed or starting a new therapy or transitioning from another therapy. What that change is like. One of the other things I tell my patients is that we all sit at the same table. I'm not better than you. Maybe I have this information, but this information is for you. It's for you to take and to improve your life. If that information doesn't work for you, then you come back to me with some feedback and we come up with something else that's going to be more helpful to you. I really think having an equal playing field with them and having a very open and honest dialogue is what is going to help our patients do the best. If patients don't feel comfortable reaching out to other local patients or connecting with an in-person support group, there are tons of online resources through the PHA, through phaware®, Team Phenomenal Hope, lots of great groups out there that do things virtually. I think in some ways for some patients, anonymity is important, so being able to protect that is an option for them, but to be able to still get what they need so they can become the best advocate for themselves that they can. Jennifer Keeley, DPN: I stress so importantly to my patients, we are here today in this great environment and we have the armamentarium of medications to treat because of patients just like you that have contributed to the science of the disease and implemented themselves and engaged in these clinical trials. Right now we have an ongoing clinical trial for seralutinib called PROSERA, that's enrolling as we speak. Patients are the best advocates, not only for themselves, but for other patients, and they talk. There's a lot of social media out there where patients communicate amongst themselves and they say, "Through the help of my provider and through the help of my family, I was hesitant to start this additional therapy." They do have, at this juncture, and I don't think it's such a bad thing, they do have a little bit of a pharmacy burden now. Again, these aren't our patients that are on one or two therapies. They're on four or more oftentimes. When you take in our ILD patients, they're also on disease modifying agents, as well, for their interstitial lung disease. So again, I think it's really important for patients to communicate amongst themselves and share their ups and downs in the disease, but also share the rewards that come with surviving and living with PAH. I think one thing that we really do have to understand though is like many other chronic diseases, PH is a personalized disease. You need to have a personalized approach for your patients. That's why it's so very important to do a really good history of your patients and understand not only what their baseline cough is, but who they are, what their personal history is. Are they working? Who's helping to care for them? Who's helping to make that chamomile tea with honey? Who's going to the store to get that? A personalized approach is so important for these patients, I can't stress that enough. Mary Whittenhall, MSN: Special thanks to everybody involved in this project. This was extremely exciting. To my co-podcaster, Jennifer Keeley, who is amazing, and all of us in the PH community are extremely lucky to have her. We are all aware that you are all rare, and we are grateful to be able to help you in this journey. Jennifer Keeley, DPN: Thank you so much, Mary, and what a pleasure it's been to speak with you about cough and inhaled therapies, and thank you to Gossamer Bio for this opportunity and for the opportunity that led to this podcast, which was a significant advisory board amongst specialists in our field, advanced practice providers and registered nurses who were able to convene in a great open space and talk about this. I think this moves our science forward. It helps us to talk about the disease and take better care of our patients. Again, my name is Jennifer Keeley. It's been such a pleasure to deal with my good friend Mary Whittenhall today, and we're aware that our patients are very rare. Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Follow us on instagram, facebook and x.com @phaware. Engage for a cure: www.phaware.global/donate #phaware Share your story: info@phaware.com Like, Subscribe and Follow us: www.phawarepodcast.com. #phawareMD #PHILD @GossamerBio @AHNtoday

With more states expected to adopt new laws, while others will be demanding more detail in existing regulations, employers are challenged to implement a unified, scalable compensation system that addresses cross-state inconsistency. In this first episode of our series, we survey the varied pay transparency landscape, detail upcoming developments, and explore how to use data both strategically and practically to mitigate legal risks, maintain compliance and improve cross-functional collaboration and decision-making amid rapidly changing laws.

AABP Executive Director Dr. Fred Gingrich is joined by Dr. Adriano Vatta, a clinical professor of parasitology at the Louisiana State University College of Veterinary Medicine. The three important parasite species in cattle include Ostertagia, Haemonchus and Cooperia, as well as liver flukes. Vatta reviews the importance of the life cycle of these parasites; the most important aspect of the life cycle is that most of it is on pasture. It is also important for veterinarians to consider climate, geography and season. Vatta explains that to mitigate resistance, we do not want to treat cattle when parasite levels are low on pasture which is contrary to what we have previously been taught.  Vatta reviews the major classes of anthelmintics available for treating internal parasites in cattle and the importance of ensuring accurate dosing to increase effectiveness as well as decrease the risk of resistance. A major factor in mitigation of resistance to anthelmintics is to utilize refugia in treatment and control programs. Refugia is the proportion of the worm population that is not treated. Utilizing fecal egg counts to determine when cattle need dewormed, as well as performing a fecal egg count reduction test to monitor resistance and efficacy, is an important service for veterinarians to offer beef cattle clients. Vatta walks through some practical tips for performing these tests as well as how to manage the number of animals selected for non-treatment as they enter the chute.  Vatta also discusses opportunities for future research to improve the practicality and compliance of performing fecal egg counts. Veterinarians have an excellent opportunity to ensure that producers are getting value from the anthelmintic products that they purchase.  Ray M. Kaplan, Matthew J. Denwood, Martin K. Nielsen, Stig M. Thamsborg, Paul R. Torgerson, John S. Gilleard, Robert J. Dobson, Jozef Vercruysse, Bruno Levecke,World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guideline for diagnosing anthelmintic resistance using the faecal egg count reduction test in ruminants, horses and swine, Vet Parasitol. 2023;Vol. 318. https://doi.org/10.1016/j.vetpar.2023.109936 Fecal Egg Count Reduction homepage https://www.fecrt.com/   

Nutritional strategies for treating Barrett's EsophagusHow can my uncle mitigate the side effects of his Merkel cell carcinoma therapy?How long can I take strontium?Is beet root powder beneficial for nitric oxide production?

A new European Union initiative to store carbon dioxide beneath the North Sea is set to launch its operations next year. But environmental activists are concerned carbon capture technologies dissuade industries from acting to reduce fossil fuel emissions.

Aviation is one of the hardest sectors to decarbonize: Between 1970 and 2023, total carbon dioxide emissions from aviation increased by around 164%, reaching nearly 1 gigatonne, equivalent to about 2.5% of all human-made carbon dioxide emissions. Mitigating these emissions will require a mix of measures, covering technology, fuels, operations and policy, as our AI Assistant Aria explains in this episode. Read the full report on our website: https://www.allianz.com/en/economic_research/insights/publications/specials_fmo/251202-aviation.html This content was generated by AI with the oversight of Allianz Research.

√ BEVERLY A. JENSEN, Ph.D., is a health champion and promoter, a life-long practitioner of natural medicine, an international speaker, trainer, and certified health coach. She's worked in more than 30 countries and lived abroad many years learning how other nations practice wellness. After training Czech physicians in the use of the internet in 1999, she founded www.WomensMedicineBowl.com in 2003. The site provides information particularly for women, who make all the family health decisions, on how to take responsibility for their own health. Since 2019, her work has focused on creating awareness of the health impacts of Electro-Magnetic Radiation from wireless. And especially how it's affecting children. The message is targeted to parents at www.YouAndEMF.com. Moms may make the family's health decisions, but in this situation, getting Dads onboard is crucial for success and the health of everyone.   Recently, legislation in Congress allowed telecom to transmit EM frequencies in national parks and nature reserves. All wildlife will be affected, beyond the birds, bees and insects—our food pollinators. While individually we cannot control corporate or government actions, there are many steps we can take to protect ourselves and our families and reduce our exposure to Electro-Magnetic Radiation. In our homes, in our workplaces and in our play we can shield ourselves. We talk about: -Radiation in our homes from routers, cell phones and Smart Electrical Meters. -Methods to mitigate exposure to EMR -How corporations  work to increase profits in lieu of safety. -How are children more vulnerable to the radiation amd how to protect them.  -Parenting groups in Facebook and Instagram to help educate adn advocate for policy change.   Moms Across America and ManhattanNeighbors.org, a safe technology group, founded by Camilla Rees.   Electromagnetic Health.org, Campaign for Radiation Free Schools, Manhattan Neighbors for Safer Telecommunications,https://www.facebook.com/EMFMomAlert/ https://www.youtube.com/@EMRadiationProtection  

Garrett Morrison returns to the feed as he joins Andy Johnson for a golf architecture mailbag episode! Andy and Garrett answer questions submitted by Fried Egg Golf Club members using FEGC's new discussion forum. The two discuss the future course ownership models, the process of rating nine-hole courses, and how artificial intelligence will impact the golf design business moving forward.

Should I Use My Savings to Delay Collecting Social Security? Episode 358 – Deciding when to collect Social Security is one of the most important financial decisions you'll ever make. Make a mistake there and you'll pay for it—every month for the rest of your life. But what if you want to retire early? That doesn't mean you also need to collect early. A “bridge” strategy can be an important tool to get you through those years between giving up your job and collecting Social Security. It could make you much better off in the long run. More SML Planning Minute Podcast Episodes Transcript of Podcast Episode 358 Hello, this is Bill Rainaldi, with another edition of Security Mutual's SML Planning Minute. In today's episode, should I use an annuity or my savings to delay collecting Social Security? So, you're getting near that age. You want to retire when you reach age 65 and become eligible for Medicare, and you're almost there. How are you going to finance it? There's no doubt you're going to miss having a steady paycheck. Should you file early for your Social Security benefit? That will replace at least some of your lost paycheck. You'll need to start by taking a look at some numbers. Let's say that, according to your statement from the Social Security Administration, your “Primary Insurance Amount,” or the benefit you would get at Full Retirement Age, which is age 67, is $3,000 per month. But if you collect at 65, you're starting two years early. Your benefit would be permanently reduced to $2,550 before annual cost of living adjustments.[1] It’s the permanent part that causes concern. If you live to age 85, you're giving up $450 per month for the 18 years between 67 and 85. On the other hand, if you were to wait until age 70 to collect, you would get $3,720 per month. You'd have to forego the five years of benefits, but your retirement from age 70 on is likely to be a bit more comfortable. And “longevity risk”—in other words, the possibility of outliving your money—is one of the biggest issues people face in retirement. Waiting until 70 helps minimize it. So, which option is better? It would be an easy choice if you knew exactly how long you're going to live. But of course, none of us do. If you end up dying at age 71, you would have been better off collecting early. If you end up living well into your eighties, you'll have more money overall if you choose to wait. And then there's the issue of the Social Security Trust Funds. They're running out of money, and expected to go bankrupt in the year 2034. But that doesn't mean your payment will disappear. If nothing is done between now and then, all payments will be reduced by approximately 19 percent. [2] This has caused some people to collect early.[3] But there is a reasonable chance that the people in Washington will “fix” Social Security before any payments are reduced.[4] That's what they've always done in past.[5] No guarantees, of course, but it seems highly unlikely politicians will allow benefits to be dramatically reduced. So, getting back to our original issue, what if you've got a good life expectancy? It would probably be best to wait until age 70 to collect, but you're planning on retiring at age 65. How are you going to get by for those five years in between, when you no longer have a paycheck, but haven't started collecting your Social Security? This is where you may want to look at some sort of “bridge” strategy. Mitigating longevity risk is a good reason to implement a bridge strategy, but there's more. According to a recent study, if you have the money to implement a bridge strategy, you can also meaningfully raise your standard of living without increasing your chance of running out of money in retirement.[6] The increased monthly Social Security benefit helps provide a dependable stream of income for the recipient which can allow for greater flexibility with remaining savings and investments. There are several possibilities when it comes to getting through that gap. If you're worried about no longer having a steady paycheck, one popular option is to purchase an annuity to provide you with the income you need to get you from 65 to 70. It can certainly help alleviate your anxiety. A single-premium immediate annuity is something that tends to work well with a Social Security bridge strategy.[7] But you need to shop around. And for the purposes of bridging the gap, you can get an annuity with a specific term. A five-year annuity would work well with the example we are using here. The other main bridging alternative is to use some of your accumulated savings. In a recent study, actuary and retirement specialist Ken Steiner concluded that using accumulated savings for Social Security bridge strategies can work well if: You expect to live longer You have enough assets that you can fund your bridge payments relatively easily You want to bolster what he calls your “floor portfolios,” that is, your less risky investments, and… You have other assets which can be invested in more risky places.[8] In the end, the financial decisions you make in your 60's are likely to have a huge impact on the rest of your life and deciding when to collect Social Security is one of the most important of those decisions. Make a mistake there and you'll pay for it every month for the rest of your life. Like so many other things, deciding when to collect Social Security can be complicated. It's best to have a skilled and trusted professional by your side to help you avoid any pitfalls. Your Security Mutual Life insurance agent can help. Your Security Mutual Life insurance agent will assemble your team and coordinate with your attorney and tax professional to review your situation and to determine the insurance plan that will best suit your needs and objectives. [1] Social Security Administration. “Early or Late Retirement?” SSA.gov. https://www.ssa.gov/oact/quickcalc/early_late.html (accessed October 9, 2025). [2] Social Security Administration. “Social Security Board of Trustees: Projection for Combined Trust Funds One Year Sooner than Last Year.” SSA.gov. https://blog.ssa.gov/social-security-board-of-trustees-projection-for-combined-trust-funds-one-year-sooner-than-last-year/ (accessed October 9, 2025). [3] Steiner, Ken. “Should Your Clients Use Savings to Defer Social Security?” Advisorperspectives.com. https://www.advisorperspectives.com/articles/2025/08/19/should-clients-use-savings-defer-social-security? (accessed October 8, 2025). [4] Horsley, Scott. “Social Security benefits face big cuts in 2033, unless Congress acts.” NPR.org. https://www.npr.org/2025/06/18/nx-s1-5436828/social-security-benefits-cut-congress (accessed October 9, 2025). [5] Social Security Administration. “SUMMARY of P.L. 98-21, (H.R. 1900) Social Security Amendments of 1983-Signed on April 20, 1983.” SSA.gov. https://www.ssa.gov/history/1983amend.html (accessed October 9, 2025). [6] Manganaro, John. “This Social Security Strategy Gives Retirees More to Spend.” ThinkAdvisor.com. https://www.thinkadvisor.com/2025/09/03/this-social-security-claiming-strategy-reliably-lifts-retirement-income/ (accessed October 8, 2025). [7] Christian, Rachel. “How an annuity can help you delay Social Security and retire early.” Bankrate.com. https://www.bankrate.com/retirement/bridging-the-gap-to-social-security-with-an-annuity/ (accessed October 8, 2025). [8] Steiner, Ken. “Should Your Clients Use Savings to Defer Social Security?” Advisorperspectives.com. https://www.advisorperspectives.com/articles/2025/08/19/should-clients-use-savings-defer-social-security? (accessed October 8, 2025). More SML Planning Minute Podcast Episodes This podcast is brought to you by Security Mutual Life Insurance Company of New York, The Company That Cares®. The content provided is intended for educational and informational purposes only. Information is provided in good faith. However, the Company makes no representation or warranty of any kind regarding the accuracy, reliability, or completeness of the information. The information presented is designed to provide general information regarding the subject matter covered. It is not to serve as legal, tax or other financial advice related to individual situations, because each individual's legal, tax and financial situation is different. Specific advice needs to be tailored to your situation. Therefore, please consult with your own attorney, tax professional and/or other advisors regarding your specific situation. To help reach your goals, you need a skilled professional by your side. Contact your local Security Mutual life insurance advisor today. As part of the planning process, he or she will coordinate with your other advisors as needed to help you achieve your financial goals and objectives. For more information, visit us at SMLNY.com/SMLPodcast. If you've enjoyed this podcast, tell your friends about it. And be sure to give us a five-star review. And check us out on LinkedIn, YouTube and Twitter. Thanks for listening, and we'll talk to you next time. Tax laws are complex and subject to change. The information presented is based on current interpretation of the laws. Neither Security Mutual nor its agents are permitted to provide tax or legal advice. The applicability of any strategy discussed is dependent upon the particular facts and circumstances. Results may vary, and products and services discussed may not be appropriate for all situations. Each person's needs, objectives and financial circumstances are different, and must be reviewed and analyzed independently. We encourage individuals to seek personalized advice from a qualified Security Mutual life insurance advisor regarding their personal needs, objectives, and financial circumstances. Insurance products are issued by Security Mutual Life Insurance Company of New York, Binghamton, New York. Product availability and features may vary by state.​ SubscribeApple PodcastsSpotifyAndroidPandoraBlubrryby EmailTuneInDeezerRSSMore Subscribe Options

A Richmond City Councillor is putting forward a motion at Richmond council that calls on the province and federal governments to mitigate the effects of the Cowichan court ruling. Perched on the waterfront of scenic northern Vancouver Island and one of the most remote pubs in British Columbia, Scarlet Ibis Pub is officially up for sale. How B.C.'s Attorney General is reacting to social media platform, 'X', challenging an order to remove a non-consensual intimate image. Learn more about your ad choices. Visit megaphone.fm/adchoices

Who counsels the counselor? Are you building systems to prevent risk, or patching problems after they appear? When was the last time you checked whether your employment practices could stand […] The post GPBC25 Series: Mitigating Risk and Employment Law with John David Gardiner | POP 1296 appeared first on How to Start, Grow, and Scale a Private Practice | Practice of the Practice.

In this week's episode, Jenny Stone and Katie Singer discuss fraud within General Practice. They cover the type of fraud you are most like to encounter and what steps you can take to mitigate fraud occurring in the practice. RBP are one of the leading medical specialist firms of chartered accountants in the UK. They have over 30 years' experience in the medical field and they will be sharing their broad and experienced knowledge through their fortnightly Accountancy on Prescription podcasts. Listeners who will be interested in subscribing to these informative and relevant shows are doctors in general practice, locum doctors, hospital consultants, practice managers and PCNs. RBP can be contacted via their website www.rbp.co.uk; by email info@rbp.co.uk or call 020 8370 7777. We are always here to help. The content of RBP's podcasts has been obtained from, or is based on, sources that we believe to be accurate and reliable. Although reasonable care has been taken in gathering the necessary information, we cannot guarantee the accuracy or completeness of any information we broadcast in our shows. We accept no liability for any errors or omissions in information provided by the RBP team or their guest speakers. You should always carry out your own independent verification of facts and data prior to making any investment, legal or tax decisions.

Rancho Mesa's Alyssa Burley sits down with Sam Clayton, Vice President of the Construction Group to discuss why having third-party subhauler agreements is recommended if you hire a third-party to move a piece of heavy equipment or use someone to import/export material from a project. Show Notes: ⁠⁠⁠⁠⁠⁠⁠Subscribe to Rancho Mesa's Newsletter⁠⁠⁠⁠⁠⁠Host: ⁠⁠⁠⁠⁠⁠Alyssa Burley⁠⁠⁠⁠⁠⁠Guest: ⁠⁠⁠⁠⁠⁠Sam Clayton⁠Editor: ⁠⁠Megan Lockhart⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Music: "Home" by JHS Pedals, “Breaking News Intro” by nem0production© Copyright 2025. Rancho Mesa Insurance Services, Inc. All rights reserved.

Toxins don't just affect your body; they shape your emotions, thoughts, and how you experience the world. In this episode, I talk with Kyle Peche, mineral-balancing coach and detox expert, about how deep detoxification can reprogram both your biology and psychology. We uncover how to minimize Herx reactions, release repressed emotions through detox, and build a stronger foundation for lasting energy, focus, and peace of mind. Kyle shares his personal health collapse at age 18, his long battle with brain fog and fatigue, and the exact steps that led him to recovery through mineral balancing and strategic detoxification. Tune in to learn the practical steps and emotional breakthroughs that can help you understand what's holding your body and mind back from real healing.   "Once I detoxed, I found myself being myself effortlessly, in flow states." ~ Kyle Peche   In This Episode: - Kyle's journey from total burnout to full recovery - The biggest detox mistakes that make people worse - About hair mineral analysis and mineral balancing - True detox symptoms vs. over-detoxification - Mitigating and preventing detox symptoms - Preventing detox reactions - How to safely restore liver health and bile flow - How repressed emotions impact detoxification - How metals like mercury and lead alter mood and behavior Products & Resources Mentioned: TruEnergy Skincare: Get this powerful combo at https://trytruenergy.com/wendy-2   Puori PW1 Whey Protein & Creatine+: Go to https://puori.com/wendy and use code WENDY to get 20% off your entire order, even on discounted subscriptions. Organifi Collagen: Save 20% with code MYERSDETOX at https://organifi.com/myersdetox  Qualia Senolytic: Get 15% off with code WENDY at https://qualialife.com/wendy  Heavy Metals Quiz: Find out if heavy metals are impacting your energy, mood, and overall health at https://heavymetalsquiz.com    About Kyle Peche: Kyle Peche is a certified mineral-balancing coach and founder of Jyoti Mineral Balancing. After suffering a severe health collapse at 18, which included fatigue, brain fog, anxiety, and digestive failure, he spent years experimenting with both medical and alternative protocols. Through hair-tissue mineral analysis and detoxification, Kyle rebuilt his health and discovered the profound emotional and spiritual changes that occur when the body truly detoxifies. Today, he helps clients restore balance, prevent Herx reactions, and transform their psychology through deep cellular healing. Learn more at https://jyotimineralbalancing.com and on Instagram at https://www.instagram.com/kyle_peche/    Disclaimer The Myers Detox Podcast was created and hosted by Dr. Wendy Myers. This podcast is for information purposes only. Statements and views expressed on this podcast are not medical advice. This podcast, including Wendy Myers and the producers, disclaims responsibility for any possible adverse effects from using the information contained herein. The opinions of guests are their own, and this podcast does not endorse or accept responsibility for statements made by guests. This podcast does not make any representations or warranties about guests' qualifications or credibility. Individuals on this podcast may have a direct or indirect financial interest in products or services referred to herein. If you think you have a medical problem, consult a licensed physician.

PREVIEW. Weightlessness Effects on Human Vision and Mars Travel Implications. Bob Zimmerman discusses a NASA study regarding the profound effect of weightlessness on the human eye. The study, looking at 28 individuals from long ISS missions, found about half had vision problems because the eye flattens in weightlessness. Though previous studies noted bone and cardiovascular issues, this new discovery found that women had less of this specific problem than men. Mitigating these effects is required for Mars travel. Retry

Hosts Regan Brown and Bill Mann, President of GB Group Construction & Painting, sit down with Cang Le, Founder and Attorney at Le Firm, to discuss the complexities of conflict resolution within homeowner associations (HOAs). Together, they explore when to involve legal counsel, how to effectively manage community disputes, and the most successful techniques for de-escalation. Cang shares insights from his extensive experience in HOA law, emphasizing the importance of preparation, active listening, and clear communication during board meetings. 

If you love what we do and want to support more of the work we do at Map It Forward, become a premium YouTube Subscriber or a paid Patreon backer here for perks: • https://www.patreon.com/mapitforward • https://www.youtube.com/mapitforward••••••••••••••••••••••••••••••••••This is the 5th episode of a 5-part series on The Daily Coffee Pro Podcast by Map It Forward with host Lee Safar and series guest, Marianella Baez Jost.Marianella is a coffee farmer (Cafe con Amor) based in Costa Rica and the co-founder of direct coffee trade project, The Farmers Project.This series is focused on coffee market volatility from the perspective of a smallholder coffee farmer in Costa Rica.The 5 episodes in this series are:1. Coffee Farming In Costa Rica in 2025 - https://youtu.be/3tHVKj65yho2. Coffee Farmers Are Adapting to the Coffee Crisis - https://youtu.be/QGUewElgLeA3. Not a Short-Term Coffee Crisis - https://youtu.be/arhcrRBWGEU4. Barriers to Direct Trade - https://youtu.be/dM75gWt1y7s5. Mitigating Risk with Direct Trade Coffee - https://youtu.be/DX0tpHrXFw0In this episode of the podcast series, Lee wraps up a captivating series with Marianella as they delve into the challenges of coffee market volatility from the perspective of small holder producers, the impact of middlemen and low-priced future contracts, and the struggles and hopes of co-ops and farmers seeking just relationships through direct trade. The discussion highlights the emergence of new direct trade models, geopolitical shifts in coffee trading, and the vital connections between small farmers and roasters. Marianella also shares the inspiring success of the Coffee Camp and encourages collaboration for a thriving coffee community. Learn more about sustainable, ethical coffee practices and how you can support these efforts.Connect with Marianella Baez Jost and The Farmers Project here:https://www.linkedin.com/in/marianella-baez-jost-00a529166/https://www.farmersproject-cr.com/https://www.instagram.com/cafeconamor.cr/••••••••••••••••••••••••••••••••Connect with Map It Forward here: Website | Instagram | Mailing list

Dan Norcross helps landlords, investors, and agents across Cheshire and the North West maximise property Income. There is hassle-free income and exceptional returns through expert property management, guaranteed rent, and serviced accommodation solutions. Tune into episode 499 of The Next 100 Days podcast to get the insights from Dan Norcross.Summary of PodcastIntroductions and backgroundKevin and Graham welcome Dan Norcross to the podcast. Dan introduces himself as a property entrepreneur who has been in the business for less than a year. He has already built up a portfolio of 6 rental properties. He explains that he is focused on the "rent to serviced accommodation" model. This provides short-term housing for contractors working on a major construction project in the local area.Scaling the rent to serviced modelDan discusses how he has been able to scale his rent to serviced model quickly. He leverages investor financing to acquire additional properties. He explains the economics of the model, noting that he is able to generate around £1,000-£2,000 per month in profit per property. Dan also shares his plans to expand into other property investment strategies like title splits and purchase lease options.Attracting investor capitalDan describes how he has been able to raise significant investor capital, around £400,000 over the past 6 months, to fund his various property deals. He discusses his approach to pitching deals and structuring the investments to provide attractive returns for his investors, often in the 30-50% range.Diversifying into larger, more complex dealsDan shares that he is now looking to take on larger, more complex property deals, including a title split project on a block of flats in Devon. He explains the mechanics of the title split strategy and how it can add significant value. Dan also discusses a purchase lease option he is pursuing on a hotel in Scotland, which will involve raising £140,000 from investors.Mitigating risks and ensuring business continuityKevin raises the question of what would happen if something were to happen to Dan, noting that he is a single point of failure in the business. Dan acknowledges this as a potential risk and agrees that he should consider putting safeguards in place, such as partnering with a management firm to ensure business continuity in the event of an unexpected absence.Recap and closing thoughtsGraham and Kevin reflect on the interesting and innovative property investment strategies that Dan has shared, noting that it has opened their eyes to new models beyond the traditional buy-to-let approach. They express admiration for Dan's ability to structure win-win deals that benefit investors, tenants, and himself, and wish him continued success in his property ventures.The Next 100 Days Podcast Co-HostsGraham ArrowsmithGraham founded Finely Fettled ten years ago to help business owners and marketers market to affluent and high-net-worth customers. He's the founder of MicroYES, a Partner for MeclabsAI, where he introduces AI Agents that you can talk to, that increase engagement, dwell time, leads and conversions. Now, Graham is offering Answer Engine Optimisation that gets you ready to be found by LLM search.Kevin ApplebyKevin specialises in finance transformation and implementing...

Wells Fargo CEO Charlie Scharf joins from the bank's new campus in Irving, Texas. Venture capitalist Bradley Tusk's solution for mitigating AI's funding issues. Plus, why Travel + Leisure says timeshares are being "rediscovered." Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Extreme weather events are reshaping the investment landscape. How can investors protect portfolios—and communities—from the rising physical risks of climate change? In this episode, Kate Webber, Chief Solutions and Technology Officer at the PRI, speaks with Dr Calvin Lee Kwan of Link Asset Management and Simon Whistler, PRI's Head of Real Assets, to explore how investors can turn climate resilience into both risk management and value creation.Overview Physical climate risk is no longer theoretical—it's here. Floods, fires, and black-rain events are increasing in frequency and intensity, with real financial consequences. Simon Whistler outlines how investors are beginning to quantify and address these risks, yet highlights that fewer than one-third of PRI signatories currently report on physical climate risk metrics. Calvin Lee Kwan shares how Link Asset Management has moved from reactive recovery to proactive resilience—reducing insurance premiums by 11.7% and strengthening investor confidence in the process.Detailed CoveragePhysical climate risk today: More frequent and severe events—from typhoons in Hong Kong to floods in Europe—are causing major financial and operational losses.Investor action gap: Only 29% of investors report on physical climate risk, compared with 50% in the real-assets space, showing the need for broader engagement.Value protection and creation: Link's sustainability strategy is built on two pillars—protecting existing value through resilience and creating new value through efficiency and stakeholder alignment.From risk to return: Engaging insurers with clear, data-driven resilience metrics translated into measurable financial results, proving sustainability can deliver bottom-line benefits.Community resilience: Floodwaters don't stop at property boundaries. Link's team now collaborates with neighbors, local authorities, and infrastructure managers to build district-level resilience—an approach that benefits whole communities.Industry-wide change: Collaboration between investors, insurers, and policymakers is key to building consistent models, pricing resilience into valuations, and driving systemic adaptation.Communication as a catalyst: For Calvin Lee Kwan, sustainability comes down to translating resilience into stakeholder-specific value—from stable returns for investors to safety and reliability for tenants.Chapters00:43 – Welcome and introductions02:08 – Why investors must act on physical climate risk05:07 – How far investors have come—and how far to go07:23 – The cost versus opportunity debate08:43 – Link Asset Management's practical approach11:48 – A watershed moment: floods and recovery13:34 – Turning resilience into measurable value15:23 – Black-rain events and extreme weather16:59 – Challenges for other investors20:23 – Partnering with insurers to price resilience25:00 – From property-level to community-level resilience27:28 – How resilience links to property valuation30:50 – Final reflections: communication, focus, and leadership32:44 – What is the responsibility of investingFor more details, visit: https://www.unpri.org/climate-change-for-private-markets/assessing-physical-climate-risk-in-private-markets-a-technical-guide/13135.articleKeywords responsible investment, physical climate risk, resilience investing, PRI podcast, Link Asset Management, insurance and sustainability, real assets, climate adaptation, community...

Segment 1: David Brauchler on AI attacks and stopping them David Brauchler says AI red teaming has proven that eliminating prompt injection is a lost cause. And many developers inadvertently introduce serious threat vectors into their applications – risks they must later eliminate before they become ingrained across application stacks. NCC Group's AI security team has surveyed dozens of AI applications, exploited their most common risks, and discovered a set of practical architectural patterns and input validation strategies that completely mitigate natural language injection attacks. David's talk aimed at helping security pros and developers understand how to design/test complex agentic systems and how to model trust flows in agentic environments. He also provided information about what architectural decisions can mitigate prompt injection and other model manipulation risks, even when AI systems are exposed to untrusted sources of data. More about David's Black Hat talk: Video of the talk and accompanying slides: https://www.nccgroup.com/research-blog/when-guardrails-arent-enough-reinventing-agentic-ai-security-with-architectural-controls/ Talk abstract: https://www.blackhat.com/us-25/briefings/schedule/#when-guardrails-arent-enough-reinventing-agentic-ai-security-with-architectural-controls-46112 Slide presentation only: https://i.blackhat.com/BH-USA-25/Presentations/USA-25-Brauchler-When-Guardrails-Arent-Enough.pdf Additional blogs by David about AI security: Analyzing Secure AI Architectures: https://www.nccgroup.com/research-blog/analyzing-secure-ai-architectures/ Analyzing Secure AI Design Principles: https://www.nccgroup.com/research-blog/analyzing-secure-ai-design-principles/ Analyzing AI Application Threat Models: https://www.nccgroup.com/research-blog/analyzing-ai-application-threat-models/ Building Security‑First AI Applications: A Best Practices Guide for CISOs: https://www.nccgroup.com/building-security-first-ai-applications-a-best-practices-guide-for-cisos/ Building Trust by Design for Secure AI Applications: Tips for CISOs: https://www.nccgroup.com/building-trust-by-design-for-secure-ai-applications-tips-for-cisos/ AI and Cyber Security: New Vulnerabilities CISOs Must Address: https://www.nccgroup.com/ai-and-cyber-security-new-vulnerabilities-cisos-must-address/ Segment 2: Should we replace the CIA triad? An op-ed on CSO Online made us think - should we consider the CIA triad 'dead' and replace it? We discuss the value and longevity of security frameworks, as well as the author's proposed replacement. Segment 3: The Weekly Enterprise News Finally, in the enterprise security news, Slow week for funding, older companies raising via debt financing A useful AI framework from the Cloud Security Alliance two interesting essays, one of which is wrong Folks are out here blasting unencrypted data to and from Satellites, while anyone can sniff and capture it getting hacked during a job interview LLM poisoning is far easier than previously thought F5 got breached Be careful when patching your Jeep ('s software) All that and more, on this episode of Enterprise Security Weekly. Visit https://www.securityweekly.com/esw for all the latest episodes! Show Notes: https://securityweekly.com/esw-429

Today on the Social-Engineer Podcast: The Security Awareness Series, Chris is joined by Carter Zupancich. Chris and Carter explore the evolving landscape of social engineering threats, focusing on the rise of vishing attacks and the role of AI in enhancing these tactics. Their discussion underscores the importance of empowering employees as a human firewall and the need for continuous education and testing to strengthen organizational security. [Oct 20, 2025]   00:00 - Intro 00:31 - Carter Zupancich Intro -          Website: https://carterzupancich.com/ 01:30 - Intro Links: -          Social-Engineer.com - http://www.social-engineer.com/ -          Managed Voice Phishing - https://www.social-engineer.com/services/vishing-service/ -          Managed Email Phishing - https://www.social-engineer.com/services/se-phishing-service/ -          Adversarial Simulations - https://www.social-engineer.com/services/social-engineering-penetration-test/ -          Social-Engineer channel on SLACK - https://social-engineering-hq.slack.com/ssb -          CLUTCH - http://www.pro-rock.com/ -          innocentlivesfoundation.org - http://www.innocentlivesfoundation.org/                                                03:35 - Tools, Tactics and Procedures 05:19 - Tech Advances 08:16 - The Classics 10:01 - The Need for Testing 12:16 - Callback Phishing 17:26 - Setting Expectations 21:56 - Approved Language 23:56 - Verify! 25:16 - Empowerment 26:17 - And Now a Horrible Story 28:47 - Investing In Employees 31:19 - Wrap Up & Outro -          www.social-engineer.com -          www.innocentlivesfoundation.org

Segment 1: David Brauchler on AI attacks and stopping them David Brauchler says AI red teaming has proven that eliminating prompt injection is a lost cause. And many developers inadvertently introduce serious threat vectors into their applications – risks they must later eliminate before they become ingrained across application stacks. NCC Group's AI security team has surveyed dozens of AI applications, exploited their most common risks, and discovered a set of practical architectural patterns and input validation strategies that completely mitigate natural language injection attacks. David's talk aimed at helping security pros and developers understand how to design/test complex agentic systems and how to model trust flows in agentic environments. He also provided information about what architectural decisions can mitigate prompt injection and other model manipulation risks, even when AI systems are exposed to untrusted sources of data. More about David's Black Hat talk: Video of the talk and accompanying slides: https://www.nccgroup.com/research-blog/when-guardrails-arent-enough-reinventing-agentic-ai-security-with-architectural-controls/ Talk abstract: https://www.blackhat.com/us-25/briefings/schedule/#when-guardrails-arent-enough-reinventing-agentic-ai-security-with-architectural-controls-46112 Slide presentation only: https://i.blackhat.com/BH-USA-25/Presentations/USA-25-Brauchler-When-Guardrails-Arent-Enough.pdf Additional blogs by David about AI security: Analyzing Secure AI Architectures: https://www.nccgroup.com/research-blog/analyzing-secure-ai-architectures/ Analyzing Secure AI Design Principles: https://www.nccgroup.com/research-blog/analyzing-secure-ai-design-principles/ Analyzing AI Application Threat Models: https://www.nccgroup.com/research-blog/analyzing-ai-application-threat-models/ Building Security‑First AI Applications: A Best Practices Guide for CISOs: https://www.nccgroup.com/building-security-first-ai-applications-a-best-practices-guide-for-cisos/ Building Trust by Design for Secure AI Applications: Tips for CISOs: https://www.nccgroup.com/building-trust-by-design-for-secure-ai-applications-tips-for-cisos/ AI and Cyber Security: New Vulnerabilities CISOs Must Address: https://www.nccgroup.com/ai-and-cyber-security-new-vulnerabilities-cisos-must-address/ Segment 2: Should we replace the CIA triad? An op-ed on CSO Online made us think - should we consider the CIA triad 'dead' and replace it? We discuss the value and longevity of security frameworks, as well as the author's proposed replacement. Segment 3: The Weekly Enterprise News Finally, in the enterprise security news, Slow week for funding, older companies raising via debt financing A useful AI framework from the Cloud Security Alliance two interesting essays, one of which is wrong Folks are out here blasting unencrypted data to and from Satellites, while anyone can sniff and capture it getting hacked during a job interview LLM poisoning is far easier than previously thought F5 got breached Be careful when patching your Jeep ('s software) All that and more, on this episode of Enterprise Security Weekly. Visit https://www.securityweekly.com/esw for all the latest episodes! Show Notes: https://securityweekly.com/esw-429

Segment 1: David Brauchler on AI attacks and stopping them David Brauchler says AI red teaming has proven that eliminating prompt injection is a lost cause. And many developers inadvertently introduce serious threat vectors into their applications – risks they must later eliminate before they become ingrained across application stacks. NCC Group's AI security team has surveyed dozens of AI applications, exploited their most common risks, and discovered a set of practical architectural patterns and input validation strategies that completely mitigate natural language injection attacks. David's talk aimed at helping security pros and developers understand how to design/test complex agentic systems and how to model trust flows in agentic environments. He also provided information about what architectural decisions can mitigate prompt injection and other model manipulation risks, even when AI systems are exposed to untrusted sources of data. More about David's Black Hat talk: Video of the talk and accompanying slides: https://www.nccgroup.com/research-blog/when-guardrails-arent-enough-reinventing-agentic-ai-security-with-architectural-controls/ Talk abstract: https://www.blackhat.com/us-25/briefings/schedule/#when-guardrails-arent-enough-reinventing-agentic-ai-security-with-architectural-controls-46112 Slide presentation only: https://i.blackhat.com/BH-USA-25/Presentations/USA-25-Brauchler-When-Guardrails-Arent-Enough.pdf Additional blogs by David about AI security: Analyzing Secure AI Architectures: https://www.nccgroup.com/research-blog/analyzing-secure-ai-architectures/ Analyzing Secure AI Design Principles: https://www.nccgroup.com/research-blog/analyzing-secure-ai-design-principles/ Analyzing AI Application Threat Models: https://www.nccgroup.com/research-blog/analyzing-ai-application-threat-models/ Building Security‑First AI Applications: A Best Practices Guide for CISOs: https://www.nccgroup.com/building-security-first-ai-applications-a-best-practices-guide-for-cisos/ Building Trust by Design for Secure AI Applications: Tips for CISOs: https://www.nccgroup.com/building-trust-by-design-for-secure-ai-applications-tips-for-cisos/ AI and Cyber Security: New Vulnerabilities CISOs Must Address: https://www.nccgroup.com/ai-and-cyber-security-new-vulnerabilities-cisos-must-address/ Segment 2: Should we replace the CIA triad? An op-ed on CSO Online made us think - should we consider the CIA triad 'dead' and replace it? We discuss the value and longevity of security frameworks, as well as the author's proposed replacement. Segment 3: The Weekly Enterprise News Finally, in the enterprise security news, Slow week for funding, older companies raising via debt financing A useful AI framework from the Cloud Security Alliance two interesting essays, one of which is wrong Folks are out here blasting unencrypted data to and from Satellites, while anyone can sniff and capture it getting hacked during a job interview LLM poisoning is far easier than previously thought F5 got breached Be careful when patching your Jeep ('s software) All that and more, on this episode of Enterprise Security Weekly. Show Notes: https://securityweekly.com/esw-429

Segment 1: David Brauchler on AI attacks and stopping them David Brauchler says AI red teaming has proven that eliminating prompt injection is a lost cause. And many developers inadvertently introduce serious threat vectors into their applications – risks they must later eliminate before they become ingrained across application stacks. NCC Group's AI security team has surveyed dozens of AI applications, exploited their most common risks, and discovered a set of practical architectural patterns and input validation strategies that completely mitigate natural language injection attacks. David's talk aimed at helping security pros and developers understand how to design/test complex agentic systems and how to model trust flows in agentic environments. He also provided information about what architectural decisions can mitigate prompt injection and other model manipulation risks, even when AI systems are exposed to untrusted sources of data. More about David's Black Hat talk: Video of the talk and accompanying slides: https://www.nccgroup.com/research-blog/when-guardrails-arent-enough-reinventing-agentic-ai-security-with-architectural-controls/ Talk abstract: https://www.blackhat.com/us-25/briefings/schedule/#when-guardrails-arent-enough-reinventing-agentic-ai-security-with-architectural-controls-46112 Slide presentation only: https://i.blackhat.com/BH-USA-25/Presentations/USA-25-Brauchler-When-Guardrails-Arent-Enough.pdf Additional blogs by David about AI security: Analyzing Secure AI Architectures: https://www.nccgroup.com/research-blog/analyzing-secure-ai-architectures/ Analyzing Secure AI Design Principles: https://www.nccgroup.com/research-blog/analyzing-secure-ai-design-principles/ Analyzing AI Application Threat Models: https://www.nccgroup.com/research-blog/analyzing-ai-application-threat-models/ Building Security‑First AI Applications: A Best Practices Guide for CISOs: https://www.nccgroup.com/building-security-first-ai-applications-a-best-practices-guide-for-cisos/ Building Trust by Design for Secure AI Applications: Tips for CISOs: https://www.nccgroup.com/building-trust-by-design-for-secure-ai-applications-tips-for-cisos/ AI and Cyber Security: New Vulnerabilities CISOs Must Address: https://www.nccgroup.com/ai-and-cyber-security-new-vulnerabilities-cisos-must-address/ Segment 2: Should we replace the CIA triad? An op-ed on CSO Online made us think - should we consider the CIA triad 'dead' and replace it? We discuss the value and longevity of security frameworks, as well as the author's proposed replacement. Segment 3: The Weekly Enterprise News Finally, in the enterprise security news, Slow week for funding, older companies raising via debt financing A useful AI framework from the Cloud Security Alliance two interesting essays, one of which is wrong Folks are out here blasting unencrypted data to and from Satellites, while anyone can sniff and capture it getting hacked during a job interview LLM poisoning is far easier than previously thought F5 got breached Be careful when patching your Jeep ('s software) All that and more, on this episode of Enterprise Security Weekly. Show Notes: https://securityweekly.com/esw-429

I have noticed the hatred towards electric vehicles growing the past five years in the natural health world. The topic has become political and there is a clinging to tradition, similar to people that didn't want to abandon the horse and buggy for the automobile, but that will pass with time. I have been saying for years: Why not see the utility and different use cases in both electric cars and gas and diesel cars? In this long time coming episode I talk about why I love owning electric vehicles being 100% off grid, the expensive lessons i've learned over the years to do it easily, how electric cars can provide ultimate freedom with solar panels, the only two car brands I found that work easily off grid, the details of my off grid setup, and I share one source of information that breaks apart every common myth you've ever heard about EVs. The biggest focus of the show is on the electromagnetic field exposure that you get riding in them. I talk about radiofrequency (RF), magnetic, and electric fields and specific supplements that fully protect your cells and mitochondria from harmful effects, namely lipid peroxidation. Human health is about adaptation, not putting yourself in a bubble. We can enjoy modern technological advancements without sacrificing our health or sovereignty.  My website: www.matt-blackburn.com My supplements: www.mitolife.co Study I referenced: https://pmc.ncbi.nlm.nih.gov/articles/PMC9608227/ Ben Sullins EV myths: https://www.youtube.com/@BenSullinsOfficial/featured

With the rapid growth in e-commerce, retailers increasingly collect and store customer data to deliver personalized shopping experiences. Yet without proper safeguards in place, unsecured data can introduce significant risk. It's not just consumer personal data that's increasingly at risk, but corporate information as well. “The retail industry is one of the most IP-intensive industries in the world, and it needs to protect its trade secrets as well as intellectual property,” said Alexander Niejelow, executive director, Hilco Global Cyber Advisors, in a fireside chat for Retail Rx with Lauren Parker, director of Fairchild Studio. Learn more about your ad choices. Visit megaphone.fm/adchoices

Fred Burton is a former cop, Special Agent and New York Times best selling author. Scott Stewart is the VP of Protective Intelligence at TorchStone Global. Both these men have long and storied resumes in the world of Protection, Security, and Protective Intelligence. Recently they have teamed up for a new book, The Protective Intelligence Advantage, Mitigating the Threat to Prominent People. This conversation is a masterclass on personal security and situational awareness. You can find their book on amazon or thier website https://theprotectiveintelligenceadvantage.com You can find Fred on his website https://www.officialfredburton.com You can find Scott on linkedin https://www.linkedin.com/in/scott-stewart-torchstone/ You can this show's sponsor RallyPointISRSolutions here https://www.rallypointisrsolutions.com and be sure to check out RallyPoints latest training! You can find our sponsor Absolute Security and Lock here http://absolutesecurityandlock.com You can find this shows website here https://www.thedistinguishedsavage.com The views, information, and opinions expressed in this podcast are solely those of the host and guest speakers and do not necessarily represent those of any associated organizations, employers, or sponsors. The opinions and views shared do not reflect the positions of our sponsors or their affiliated companies. This podcast is for entertainment and informational purposes only and should not be considered professional advice in any field including but not limited to legal, medical, financial, or technical matters. All content is provided "as is" without warranties of any kind. We make reasonable efforts to ensure accuracy but cannot guarantee that all information presented is correct, complete, or up-to-date. Listeners should verify any critical information independently. Guest opinions belong to them alone. Our interviews with various individuals do not constitute endorsement of their views, products, or services. By listening to this podcast, you agree that we are not responsible for any decisions you make based on the information provided. Please consult with qualified professionals before making important decisions related to your health, finances, or legal matters. This podcast may contain explicit language or mature themes. Listener discretion is advised. © 2025 The Distinguished Savage, Savage Concepts LLC

In this week's MBA Admissions podcast we began by discussing the current state of the MBA admissions season, with interview invites continuing to roll out. This week, Ohio State / Fisher, Notre Dame / Mendonza, Boston College / Carroll, Texas / McCombs, USC / Marshall, Indiana / Kelley, Arizona / Carey, UCI / Merage, Florida / Warrington, Rice / Jones and The Consortium all have their Round 1 deadlines. NYU / Stern has its Round 2 deadline. Duke / Fuqua, Oxford / Said and Notre Dame / Mendoza are all scheduled to release final decisions from early rounds. INSEAD and Imperial Business School are scheduled to release interview invites. Graham highlighted several upcoming events being hosted by Clear Admit this month, including a Real Humans series and a series focused on MBA programs in different regions of the United States. Signups for all these events are here, https://www.clearadmit.com/events Graham also highlighted our next livestream AMA, scheduled for Tuesday, October 28; here's the link to Clear Admit's YouTube channel: https://bit.ly/cayoutubelive. Graham noted a recently published admissions tip which focuses on which types of questions a candidate can ask their MBA admissions interviewer, at the end of the interview. Finally, Graham highlighted a Real Humans piece that focuses on Class of 2027 MBA students at ESADE in Barcelona. For this week, for the candidate profile review portion of the show, Alex selected three ApplyWire entries: This week's first MBA admissions candidate has applied in Round 1 with a GRE score of 315. They do plan to retake it and submit the new score to the schools to which they have already applied. This week's second MBA applicant is based in Canada and has a 2.9 GPA. This is due to their first two years of study, where they really struggled. They also have a 317 GRE score. We recommend they retake the test, one more time. The final MBA candidate is from Africa and is targeting European MBA programs. They need to refine their goal focus and perform well in either the GMAT or GRE. This episode was recorded in Paris, France and Cornwall, England. It was produced and engineered by the fabulous Dennis Crowley in Philadelphia, USA. Thanks to all of you who've been joining us and please remember to rate and review this show wherever you listen!

This episode is an open discussion on stress and suffering. It was inspired by an episode of "The Diary of a CEO with Steven Bartlett" where he interviews Deepak Chopra. Please go listen to this great interview HERE!Email: Info@AmateurHourPod.comSocials: @Amateur_Pod

According to the IEA’s 2025 Global Methane Tracker, methane is responsible for around 30% of the current rise in global temperature. Mitigating methane, which has more than 80x the warming potential of CO2 over a 20-year period, is critical to addressing climate change. In this episode of ESG Currents, Bloomberg Intelligence’s director of ESG research Eric Kane speaks with Olya Irzak, founder and CEO of Frost Methane, about the company’s efforts to destroy, valorize and measure emissions from manure ponds and other sources. They also talk about the volatility of voluntary carbon markets, raising capital, the current climate policy landscape and more.See omnystudio.com/listener for privacy information.

In this episode of Parallax, Dr Ankur Kalra speaks with Dr Benjamin A D'Souza, Associate Professor of Medicine at the University of Pennsylvania and Section Chief of Cardiac Electrophysiology at Presbyterian Medical Center. Together, they explore the challenges of mitigating sudden cardiac death and the evolving role of guideline-directed medical therapy in optimising patient outcomes. Dr D'Souza reflects on current strategies for risk assessment and prevention, highlighting the importance of medical therapy, careful monitoring and timely use of defibrillators. He stresses that management must be tailored to individual patients, with decisions guided by evidence, imaging and multidisciplinary collaboration. The conversation also turns to women's cardiac health and representation in electrophysiology. Dr D'Souza highlights the persistent under-enrolment of women in clinical trials and their lower access to ablation and device therapy. He stresses the need for inclusive trial design, mentorship and acknowledgement of systemic bias to improve equity in cardiovascular care. This series is supported by ZOLL and is intended for Health Care Professionals.

Join Mindy Jensen and Scott Trench on the BiggerPockets Money Podcast as they welcome retirement tax experts Sean Mullaney, The FI Tax Guy, and Cody Garrett, a certified financial planner, to break down their game-changing retirement drawdown order of operations. This isn't your typical retirement advice - it's a strategic blueprint that could save early retirees and traditional retirees thousands in taxes while ensuring their money lasts a lifetime. Discover the four critical retirement drawdown fundamentals that form the backbone of any successful retirement strategy, plus advanced tactics for optimizing your tax burden, managing healthcare costs, and timing Roth conversions for maximum impact. Sean and Cody don't just explain what to do - they walk through exactly when and why each strategy matters most, covering everything from your retirement date through the challenging widow and widower years. This episode covers: The four fundamental retirement drawdown rules that could save you thousands Why you should spend taxable accounts first and traditional accounts second The strategic case for delaying Social Security until age 70 How to use HSAs and Roth IRAs as powerful tax-free tools The five distinct phases of retirement and what each one means for your strategy Advanced Roth conversion tactics and optimal timing How to keep income low to maximize ACA premium tax credits Managing required minimum distributions and minimizing their impact Healthcare cost planning and insurance strategies for retirees Why working with a qualified tax planner is essential for your unique situation And SO much more! 00:00 Retirement Drawdown Strategies 01:22 Fundamentals of Retirement Drawdown 03:37 Phases of Retirement and Taxable Accounts 07:23 Managing Income and Premium Tax Credits 09:22 Roth Conversions and Standard Deductions 19:52 Hidden Roth IRA and Tax Planning 28:36 Navigating Healthcare Subsidies and Early Retirement 29:26 Balancing Benefits for Early Retirees and Self-Employed 33:34 Strategic Tax Planning for Retirement 35:50 Understanding Required Minimum Distributions (RMDs) 36:59 Mitigating the Impact of RMDs 40:51 The Widow's Tax Trap and Effective Tax Planning 46:30 Connect with Sean and Cody! Learn more about your ad choices. Visit megaphone.fm/adchoices

Expert tips for mitigating market risk. Why the timing of avian influenza's return could make it worse. A garlic farm in South Dakota. Minnesota cereal company cares for people and the planet.

We've heard the old adage about how it's cheaper to keep a current customer than it is to acquire a new customer but is it true? Not only is it true but it goes deeper than that. I want to explain how your retention and churn rate will affect your coaching business long term, what churn rate is if you aren't aware of it, and the value of having great coaching skills to keep clients longer. Topics include: - Coaches Always Want More, More, More- Retention and Churn Rate- Nutrition Coaching Collaborative- Review, Rate, and Share- Churn/Turnover Rate- Roster Example- Coaching Skillsets and Knowledge are Vital- Doing the Math---------- ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠My Live Program for Coaches: The Functional Nutrition and Metabolism Specialization ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.metabolismschool.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠---------- [Free] Metabolism School 101: The Video Series⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.metabolismschool.com/metabolism-101⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠----------Subscribe to My Youtube Channel: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://youtube.com/@sammillerscience?si=s1jcR6Im4GDHbw_1⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠----------⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Grab a Copy of My New Book - Metabolism Made Simple⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠---------- Stay Connected: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram: @sammillerscience⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube: SamMillerScience⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook: The Nutrition Coaching Collaborative Community⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok: @sammillerscience⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠----------“This Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast and the show notes or the reliance on the information provided is to be done at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment and is for educational purposes only. Always consult your physician before beginning any exercise program and users should not disregard, or delay in obtaining, medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. By accessing this Podcast, the listener acknowledges that the entire contents and design of this Podcast, are the property of Oracle Athletic Science LLC, or used by Oracle Athletic Science LLC with permission, and are protected under U.S. and international copyright and trademark laws. Except as otherwise provided herein, users of this Podcast may save and use information contained in the Podcast only for personal or other non-commercial, educational purposes. No other use, including, without limitation, reproduction, retransmission or editing, of this Podcast may be made without the prior written permission of Oracle Athletic Science LLC, which may be requested by contacting the Oracle Athletic Science LLC by email at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠operations⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@sammillerscience.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. By accessing this Podcast, the listener acknowledges that Oracle Athletic Science LLC makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in this Podcast."

In today's episode, we're discussing the complex and urgent topic of global food demand. The United Nations Sustainable Development Goals, or SDGs, ask countries to make measurable progress in reducing poverty, achieving zero hunger, and supporting every individual in realizing good health. While also mitigating climate change, sustaining the environment and responsible consumption and production habits. Researchers have recommended sustainable diets - planetary health diets. For example, the Eat Lancet Planetary Health Diet. However, others have criticized some of these diets for not addressing the economic and social impacts of transitioning to such diets. Is it possible to balance changing diets, rising incomes, and economic growth with economic feasibility, environmental impact, and long-term sustainability? Well, that's what our goals are today. Our guests today are Andrew Muhammad of the University of Tennessee Institute of Agriculture, and Emiliano Lopez Barrera from Texas A&M. They are my co-authors on a new paper in the Annual Review of Resource Economics entitled Global Food Demand: overcoming Challenges to Healthy and Sustainable Diets. Interview Summary Andrew let's begin with you. Why is it important to study the economics of dietary habits and food choices in a global context? Well, it's important for several reasons, right? When we think both about food security as well as environmental outcomes and maintaining biodiversity, in keeping both human beings and the planet healthy, we really do need to think about this in a global context. One could see agriculture as a global ecosystem where decisions in one country clearly have impacts on outcomes in others. While at the same time, we need to see food as a means by which we satisfy the demands of a global community. Whether it be through our own domestic production or international trade. And then the last thing I'll say, which is really most important are all the actual things we want to tackle and mitigate and correct, fix or improve. Whether it be the environmental issues, global food security outcomes, individual diets, mitigating obesity issues globally, right? It's pretty clear that most of the things affecting human beings in the environment as it relates to agriculture are global in nature, and there's an economic component that we need to consider when addressing these issues in a global context. Thank you for sharing that. And I am interested to understand what the role of economics in dietary habits is as we explored it in this review paper. In economics, this is a pretty long history, one could say going back centuries, right? This idea of how income growth impacts food spending on a household or individuals, as well as what economic affluence in development does to sort of how diets transition. And so, for example, it's been long established, right, as individuals get richer, a smaller and smaller share of their income is spent on food. So therefore, food dynamics become less important in [a developed, rich country versus a developing country where a large percentage of income is still spent on food. And what does that mean? That means that while I may find price shocks annoying, and while I may find higher grocery prices annoying, in a developing world that clearly has some implications on the nutritional needs and food decisions far more than it would have on me, for example. But the other thing which is something that has been highlighted for quite some time, and that is this transition from basic staples - from rice, grain, corn, cassava, potatoes, etc. - to more complex food products like high protein dense meat products, fish, milk, dairy, and even highly processed products that are deemed unhealthy. But the point is, as we look at the full spectrum of countries from least developed to most developed, you see this transition from basic staples to these protein dense products as well as complex processed products. This is a really important point about what are the trends across countries and over time as incomes change and as global prices affect choices. And I do appreciate what you're saying about those of us in, say a country like the United States, where we may be able to absorb some of the shocks that may happen with food prices, we also recognize that there are folks from lower income households where those kinds of price shocks can be really challenging. That's true. But this is a different story when we're then talking about developing countries and some of the challenges that they face. Thank you for sharing that. I'm also interested in understanding what do economists mean by a nutritious and sustainable food demand, especially in the context of global or cross-country comparisons. What are some of the things that you uncovered in this review? Yes, and I think the main thing, which is particularly interesting, is how early diets transition. How quick countries go from being staple dependent to sort of relying more on protein in consumption and demand. And that happens pretty early and so long before you get to say, countries like the United States with a per capita income of around $50,000 per person, you start seeing transitions quite early, right? Whereas income goes from say less than a $1,000 per person to maybe $5,000 and $10,000, you see these transitions right away. And in fact, you begin to see things level off. And what that means is when we think about, for example, animal protein production, which is in the context of dairy and beef, which is considered relatively more harmful to the environment than say poultry production. What you do find is that in these developing countries, they really do transition right away to meat with just minimal income growth. Whereas at the same time, when you start seeing income growth at the higher end of the spectrum, you don't see that much of a change. Now, something that's also unfortunate, what you find is that with income growth, you do see decrease in consumption of vegetables. A part of that is that some staples are counted as vegetables, but another part of that is that wealth and influence doesn't necessarily lead to improved diets. And that's something that's unfortunate. And what it says is that interventions are possibly needed for these improved diets. But to really get back to your question, this idea when we say sort of a nutritious diet, obviously we're thinking about diets that satisfy the nutritional needs of individuals. While at the same time mitigating unhealthy outcomes. Mitigating obesity, cardiovascular disease, etc. But then coupled with that is this whole notion of sustainable agricultural production. And I think one of the difficult things about both nutritious and abundant food as well as environmental outcomes, is we really are thinking about sort of trade-offs and complementarities. Then I think economics gives us a real keen insight into how these things play out. Andrew, you make me worry that we're locked in. That is as soon as income start to rise, people move to more animal protein-based products. They move away from some fruits and vegetables. And knowing that the environmental consequences of those choices and even the health consequences, my question to you is what kinds of interventions or how do you think about interventions as a way to shape that demand? Is that an appropriate way to think about this? Alright, so there's a few things. One is just sort of provide nutrition education globally. Having countries and their governments sort of understand these outcomes and then making a concerted effort to educate the public. The other thing is what you often do see is incentivized, for example, fish consumption. Incentivizing poultry production. And you do actually see a lot of incentives for poultry and egg consumption. And I think of like the Gates Foundation in that One Egg a Day initiative to help with child stunting and child growth in the developing world. And so, they're clearly protein alternatives to bovine type products. And I have to be clear here. Like I'm only speaking about this in the context of what's being said, in terms of the environment and animal production. But the other thing I think, it's probably even more important, right? Is this idea that we really do need to rethink how we, both in the developing world as well as in the developed world, rethink how we think about nutrition and eating. And that's just not for developing countries. That's for all countries. And obviously there's one last thing I'll highlight. You do have to be sort of concerned about, say something like taxes. Which would be clearly regressive in the developing world, and probably much more harmful to overall consumer welfare. The point is that taxes and subsidies seem to be the policy instruments of choice. Great. Thank you for that. Andrew has just shared with us some of the issues of what happens as incomes rise and the changing patterns of behavior. And that there are some implications for sustainable diets. Emiliano, how can we use the type of data that, Andrew talked about to model food systems in terms of health and nutrition. What can we learn from these models and, what should we do with them? Emiliano – Yes, thank you. Andrew really pointed to like many very important issues, aspects. We see some worrisome trends in the sense that current diets are going in the direction of showing less nutritious. Also, we are looking at a lot of issues in the environmental externalities, embedded resources. A lot of that within the current diet trajectory. Economic models, they have this advantage that they can connect these things together, right? Each time that we decide what we are purchasing for eating each day we are deciding in a combination of these resources embedded in the food that also some potential nutritional outcomes or health outcomes related to that diet. And the models help to connect these things very well. We can trace this back from more, sort of naive approach where we do have lifecycle assessments where you just track the account numbers through the different stages of the food. And you can just basically trace the footprint or head print of the foods. But you can come up with more advanced models. We have seen a huge advance on that area in the last 10-15 years where models can really connect the things in a more holistic approach. Where you can connect the demand systems and the supply system both together. And then from and calibrate the models. And then also they're very useful to project to the future, different states of the world in the future. By doing that sort of exercises, we can learn a lot of how these things are connected, and how potential different pathways towards the future will also have potential different outcomes in terms of nutrition. But also, in terms of environmental pressure. We can model things, for instance, we were talking a little bit on how to shape these different sorts of diets. That's a thing that is advancing more and more in the modeling literature. We can see that people are going from these earlier approaches where we just get a particular diet that we have as a goal, and then we use that as a sort of counterfactual compared to the baseline sort of trajectory. Now we are looking more and more people doing exercises like how we can actually get there with this, for example, differential value added taxes where you kind of harm some type of food and then you kind of incentivize the consumption of others, as Andrew was saying. And we are looking at a lot of those sort of exercises at the global level, localized, and we are learning a lot of these intricate relations from the models. I think that's bottom line. And in that sense is models are really well equipped to this problem in the sense that show this holistic picture of the issue. Thank you for that. And what we've been learning from these models is this holistic picture, but can you tell us anything about how these models help show these relationships between diet and health outcomes and environmental sustainability? I mean, what's happening? Are we seeing models help predict the greenhouse gas emissions or changes in cardiovascular outcomes? What are you seeing? Well, typically when we do baseline projections, we use a lot of end use information where we have been studying things backwards, and in these integrated relationships. And when we look into the future, these relationships get stronger. Like some low income, middle countries tend to sort of repeat similar patterns of things that we have seen already in more industrialized countries. We have all this nutrition transition that comes strong. Pretty fast and pretty strong within the models. And when we look forward, the problems are not only going to be like the ones we see now, but probably somewhat worse. Especially in the pressure on the use of natural resources. So that's one thing that we have seen. Another thing that we have seen is that there can be a lot of potential multiple dividends of alternative pathways, right? We have this sort of baseline situation where diets kind of go that way and they become less sustainable, less healthy. We have dual burdens, multiple burdens of malnutrition rising in many countries at the same time. But then when we kind of model this counterfactual situation where what if we get a different diet that can follow certain guidelines or a flexitarian diet or even a vegan diet, whatever. All of those things can bring together some multiple dividends in the sense that you can certainly reduce the pressure on the use of natural resources in many degrees. And then also at the same time, you can reduce the burden of the health outcomes. That's a thing that we have been learning. Another thing that is interesting and is really strong in the model is that you can actually see a lot of synergistic things, synergistic goals that we can learn, but also a lot of potential tradeoffs, right? When we shift towards these sorts of alternative diets in an ideal world, well then, a lot of sub populations in certain parts of the world may suffer that thing too. There are multiple benefits, but also there are a lot of tensions. And we are learning more and more about those as well. And models actually showing those synergistics, but also some of these potential trade-offs in a very, very interesting way. Thank you for sharing that because one of the topics I was interested in understanding is can folks actually afford these diets? I mean, there was a lot of controversy around, or concern around an Eat Lancet diet in saying can people afford this. And we actually review that in the paper. What you're telling me is that there is a possibility of understanding distributional effects within societies of if we move our diets in this certain way who's able to afford it. Whether the implications for lower income folks in that society as compared to other model diets. Is that a fair assessment of some of the work that you've seen? Yes, absolutely. If, for instance, when we're doing the models, I'm going to put an example, we do this sort of incentivizing certain kind of foods and we put high taxes on other kinds of foods. Well one thing that is interesting is that all of these potential benefits or spillovers or global spillovers are really interconnected with also trade policies. And global models can tell us a really compelling story about that. In a more connected sort of world, when you do something in certain region that can have some benefits, then that creates spillovers to others. Let's say you reduce the demand of food in certain regions, certain countries, you can shape that. Then that globally through global markets can affect the accessibility or affordability of food in other regions. In that sense, those two things are connected and bring some benefit. But when you look at deeper in that particular region where you're trying to intervene with certain taxes for certain kind of foods, it is obviously going to bring some challenges. Some equity challenges because those particular areas that are devoted to produce that kind of food are also related to a lot of workers, a lot of producers, farmers, etc. And a lot of those are going to get the negative effects of this sort of policies. So that's one side. Then the other side is, yeah, when you affect prices, prices affect obviously the consumers as well. And again, in those certain regions when you have some population that is already are having some challenges to afford certain kind of food, if you impose a tax, then that again will handle those population. There is a lot of work to do to look at the details. And sometimes global models or two aggregated models can fail short in that direction. But we see that in an aggregated world, let's say. Yes, I appreciate and want to pick up on both something you and Andrew have been really pushing. Is this interconnectedness. Once we intervene in one part of the market or in even one part of the world, there are reverberations throughout. And these models sound really rich, and you started to hit on something that I want to learn a little bit more. And it's this idea that the models aren't perfect. Can you tell us a little bit more about some of the limitations of these models, especially as it relates to policy design or policy discussion? Yes. Well one thing that is, and the more you look at these things, is some of these models or mostly global models, they do have again this benefit that you can see many things interconnected at the same time. But that then you have to neglect something. There is a trade off in that decision. And typically, you are looking at things at a slightly aggregated sort of level. So typically, you have a average representative consumer or an average representative producer in a different region or a different country. With that, you then could miss a lot of the heterogeneous effects that a policy or a counterfactual state of the world will have on a certain population. In many cases we will fall short on that. And one thing that we have seen, and it's really cool, and I think it's a really good advancement in recent years more, people is doing, is that sort of multi-scale kind of approach where you do have a sort of global model to solve certain situation and then with that you calibrate in a more granular type of level of model. That sort of multi-scale approach it's working pretty well to see more of these multi-level effects. But sometimes global models can fail short on getting a heterogeneous result, I guess. Thank you for sharing that. And it's important to understand that models are not perfect, and that we're regularly as a discipline, as a field, we're always working on improving the models, making them more realistic, and more responsive to policy shifts. And so that begs this question, and then I'm going to open this up first to Andrew and then back to you, Emiliano. In this review paper, we were looking at the state of the world, the state of the art of research in this space. And my question to you both is what are some places where you see a need for new research or new research questions that we haven't really dealt with? What are you seeing as important places to go here? Here's the thing. I wouldn't necessarily refer to it as sort of new research, but certainly where we definitely need more research. And so, for those studies that continue to link greenhouse gas emissions with animal protein production, and really trying to think about what that would necessarily mean if we in some way mitigate animal protein production. Particularly let's say cattle and dairy. What does that necessarily mean for countries at the lower end of the spectrum where that initial demand for protein is needed. While at the same time we're not seeing changes in the developing world. The point is, where do we get the most bang for our buck? Do we get the most bang for our buck environmentally by trying to mitigate consumption globally? Or in some way trying to mitigate consumption, say in the United States and Europe, while at the same time letting Botswana and other countries carry through on that dietary transition that would otherwise occur. And I do think I've seen studies like that. But I do think this whole issue of where best to mitigate meat production and where best to sort of let it go. The other thing, and we're going to continue with this going forward. And that is particularly in the developing world this idea of how one manages both rising obesity and rise in malnutrition all at the same time. Like that is a very sort of precarious position for governments to find themselves in. One, having to both feed people more than what's available, while at the same time having a subset of the population eating too much. Whereas unlike the United States where we could pretty much have a blanketed dietary strategy to try to reduce size, girth, and just sort of eating habits. In the developing world, you really do have to manage the dual negative outcomes of both obesity as well as malnutrition. Great. Thank you. And I really appreciate this idea of where do we target interventions? Where do we, as you said, where do we get the biggest bang for our buck? And then this really complicated tension of some folks is experiencing food security challenges, others are facing issues around obesity. And we actually see in some places where those two things come together really complex ways. What's the right set of policies to actually solve both of those problems? And how do you do that well? Emiliano, what are you thinking about in terms of new directions or areas to go? So, in terms of approaches like more in a technical way, but I'm going to be brief from this I promise, I feel that there is a lot of work to do in multilayer modeling. I think that's a really exciting avenue that people are trying. And there are different ways to go from top bottom sort of approaches in the demand spectrum, but also in the resource embedded spectrum. So that's pretty exciting. But then topically, I think Andrew covered pretty well. I will say also that we do have the multiple burdens of malnutrition. On top of that thing that I would mention is the food waste. A thing that I have learned in the past that food waste is a big portion of the overall purchasing basket. And it's coming pretty clear still is way sort of underdeveloped kind of area because it's a very difficult thing to measure. There are not a lot of papers that can address this globally or look at long run trends and things like that. But it's typically mirroring the dietary transition as well. But we really need to learn how that looks. Is this a thing that we used to think 5-10 years ago? It was more like a sort of static problem in rich countries that they tend to waste food. But now we're looking more and more that this is an increasing problem in more developing countries, emerging economies. And as soon as we get certain threshold of income, people start purchasing more than what they need. And then we see more and more food waste. And that area I think is somewhat overlooked or still a good challenge to be addressed. And then from there, when you look at that, we should look at how that again enters the big picture, right? I mean, there are a couple of papers that have combined these changes in diets, reducing food waste as a part of it, and so like that. But still there is a lot of work to do on that. We tend to think also, and again, similarly to with the other things, that food waste is not a great thing. It's a clear sign of inefficiency in the global food system. Food waste itself also has a lot of embedded resources, right? One of them is labor. So, we just try or do a huge amount of effort to just reduce or eliminate food waste or reduce in a big portion of food waste. Then what's going to happen with a lot of employment that it was devoted to that. I think that particular fact is somewhat overlooked too. But again, those are the sort of areas I would be excited to look in the near future. I really appreciate this point about food waste. That's an area that I've been working on mostly in the US. And I agree, I think there's some critical places for us to consider. And also thinking about what that means for modeling. I know with the Thrifty Food Plan here in the United States, there's an assumption of a 5% food waste and that's a big assumption. When you can imagine just how different households may respond to incentives or how prices may influence their choice or maybe even lack of choice as food waste does occur. So, I think you are touching on some really important points, and I really like how, Andrew, you're talking about the importance of targeting. Bios Andrew Muhammad is a professor of Agricultural and Resource Economics at the University of Tennessee Knoxville. He is an expert in international trade and agricultural policy. He assists state and national agricultural decision-makers in evaluating policies and programs dealing with agricultural commodities, food and nutrition, natural resources, and international trade. Emiliano Lopez Barrera is a visiting assistant professor in the Department of Agricultural Economics at the University of Texas A&M University. His current research focuses on understanding how future patterns of global food consumption will affect human health, and how the agricultural changes needed to support the ongoing global nutrition transition will affect the environment. He combines econometric tools with economic and nutrition modeling to explore the trade-offs and linkages among diets, human health, and environmental sustainability. Prior to his grad studies, he worked as a consultant for the Inter-American Development Bank at the Central Bank of Uruguay. 

September 18, 2025- State Homeland Security and Emergency Services Commissioner Jackie Bray discusses the risk of political violence in New York and considers how the political discourse can contribute to violence.

Sponsors:• ◦ Visit Buildertrend to get a 60-day money-back guarantee on your Buildertrend account• ◦ Marvin Windows and Doors• ◦ Sub-Zero Wolf Cove Showroom PhoenixConnect with Tyler Woodruff:https://www.leavitt.com/woodruff/staff/tyler-woodruffConnect with Brad Leavitt:Website | Instagram | Facebook | Houzz | Pinterest | YouTube

What if achieving success had nothing to do with setting goals—and everything to do with making decisions you can't turn back from?In this episode of Decidedly, we sit down with Dr. Apollo Emeka – former Green Beret, FBI analyst, and business strategist – to uncover why goals keep so many leaders stuck, and why reframing them as decisions is the key to real progress. From evacuating during California wildfires to moving to Panama in just 30 days, Dr. Emeka shares hard-earned lessons in high-stakes decision-making, breaking default patterns, and leading with conviction.We dive deep into his military-honed frameworks for making confident business choices, the science of commitment, and why creative constraints can be your biggest competitive advantage. If you've ever hesitated to take action because you didn't feel “ready,” this conversation will change how you move forward—fast.KEY TOPICSWhy you should eliminate “goals” from your vocabularyThe three types of decisions: inherited, default, and bigHow to break patterns of indecision in business and lifeThe neuroscience of commitment and why it mattersHow to create urgency and creativity through constraintsLessons from Special Forces and FBI intelligence analysisThe “most dangerous” vs. “most likely” risk frameworkHow moving to Panama in 30 days shaped his philosophyAligning decisions with happiness and purposeActivating your team's creativity through clear decisionsCHAPTERS00:00 Introduction02:15 Why Constraints Create Creativity04:00 Dr. Apollo's Path from Green Beret to Business Coach06:40 Inherited, Default, and Big Decisions Explained09:15 Why Most Goals Don't Actually Excite You14:20 How to Craft a Decision That's a “10” on the Happiness Scale19:00 The 30-Day Move to Panama – Breaking Comfort Zones21:45 Special Forces Decision-Making Framework24:10 Finding and Mitigating the “Most Dangerous” Risk29:00 The Power of Commitment in Leadership33:00 Why You Should Lead with Emotion, Not Just Logic38:00 Creating Messy, Inspiring Decisions for Your Team41:00 The One Tip Every Business Owner Needs#DecisionMaking #BusinessLeadership #EntrepreneurMindset #LeadershipTips #BusinessGrowth #GoalSettingAlternatives #BigDecisions #DrApolloEmeka #GreenBeretLeadership #FBIInsights #MindsetShift #ConfidentDecisions #LeadershipDevelopment #EntrepreneurSuccess #BusinessPodcast #DecidedlyPodcast #PurposeDrivenBusiness #CreativeConstraints #LimbicBrain #SuccessMindsetCONNECT WITH USwww.decidedlypodcast.com Join us on Instagram: www.instagram.com/decidedlypodcast Join us on Facebook: https://www.facebook.com/decidedlypodcast Shawn's Instagram: www.instagram.com/shawn_d_smith Sanger's Instagram: www.instagram.com/sangersmith MAKING A FINANCIAL DECISION?At Decidedly Wealth Management, we focus on decision-making as the foundational element of success, in our effort to empower families to purposefully apply their wealth to fulfill their values and build a thriving legacy.LEARN MOREwww.decidedlywealth.com SUBSCRIBE TO OUR WEEKLY DECISION-MAKING TIP EMAILJoin us every Wednesday for more strategies to DEFEAT bad decision-making - one episode at a time!CONNECT WITH DR. APOLLO EMEKAWebsite: https://www.apollostrategy.com/  LinkedIn: https://www.linkedin.com/in/apolloemeka/ Dr. Apollo Emeka is the Founder and CEO of Apollo Strategy Group, a leadership and strategy consultancy that has generated over $500M in value for more than 100 leaders and organizations. A former U.S. Army Special Forces Green Beret and FBI intelligence analyst, he blends two decades of high-stakes experience with a Doctorate in Policy, Planning, and Development from USC. Known for turning diversity, equity, inclusion, and accessibility into engines of innovation, Dr. Emeka draws on his personal journey, from dropping out of high school to becoming a decorated military leader and trusted advisor, to help business owners make bold, high-impact decisions that align with purpose.

This episode is brought to you by Eight Sleep, the leader in sleep fit technology. Their award-winning Pod 5 sleep system helps you fall asleep faster, stay asleep longer, and wake up feeling more refreshed by automatically adjusting to your ideal temperature, elevation, and sound throughout the night. Upgrade your rest and your recovery: use code VALERIA for $350 off at http://eightsleep.com/valeria  In this insightful and inspiring episode, Valeria sits down with Alex Zatarain, co-founder of Eight Sleep, to discuss how she's transforming the way we think about rest, recovery, and performance. Alex shares the story of building one of the most innovative sleep technology companies in the world, from identifying the gap in the market to creating the Pod - a smart mattress designed to personalize and optimize your sleep. Together, they explore the science behind quality rest, the connection between sleep and mental health, and how technology can help us live longer, healthier lives. Alex also opens up about the challenges of entrepreneurship, balancing ambition with self-care, and the habits that keep her grounded. Whether you're an aspiring founder, a tech enthusiast, or simply someone who wants to sleep better, this episode offers actionable takeaways and a behind-the-scenes look at a brand changing the future of sleep. Shop my looks from this episode: https://shopmy.us/collections/2101362?tab=collections  

Check the episode transcript hereABOUT BRAD JOHNSONBrad is the Founder and CIO of Evergreen Capital. Brad has 20 years of experience investing in both traditional and alternative asset classes with a primary focus on high-cash-flowing assets. Brad is also a Partner of Vintage Capital, which focuses primarily on mobile home park investments. Previously, Brad worked as a real estate private equity operator. Early in his career, Brad worked at Wells Fargo's real estate investment bank and held various investment positions with private equity firms. Brad has closed over $3.3 billion in commercial real estate acquisitions over the course of his career.   THIS TOPIC IN A NUTSHELL: From investment banking to private equityBecoming an owner/operator Manufactured housing as a niche Advantages & Resilience of Affordable Housing Operational Challenges of Managing Underperforming ParksHaving the right market, occupancy levels, and management teamEvergreen Capital's three primary verticalsShift Toward Debt InvestmentsMinimizing downside risk vs. chasing 10x returnsLong-term compounding and Short-term capital gains Open-ended investment structures Connect with Brad  KEY QUOTE: “Real estate isn't about hitting home runs. It's about consistently hitting doubles while protecting your downside.”  ABOUT THE WESTSIDE INVESTORS NETWORK   The Westside Investors Network is your community for investing knowledge for growth. For real estate professionals by real estate professionals. This show is focused on the next step in your career... investing, for those starting with nothing to multifamily syndication.     The Westside Investors Network strives to bring knowledge and education to real estate professionals that is seeking to gain more freedom in their life. The host AJ and Chris Shepard, are committed to sharing the wealth of knowledge that they have gained throughout the years to allow others the opportunity to learn and grow in their investing. They own Uptown Properties, a successful Property Management, and Brokerage Company. If you are interested in Property Management in the Portland Metro or Bend Metro Areas, please visit www.uptownpm.com. If you are interested in investing in multifamily syndication, please visit www.uptownsyndication.com.   #ManufacturedHousing #AffordableHousingCrisis #RealEstateInvesting #PrivateEquity #GPStakes #CommercialRealEstateDebt #MobileHomeParks #AlternativeInvestments #HardAssets #AssetAllocation #InvestmentBanking #CashFlowInvestments #RiskAdjustedReturns #LongTermHold #TaxEfficientInvesting #EvergreenCapital #DebtInvesting #RealEstatePortfolio #LimitedPartner #GPInvestor #PassiveIncome #CashFlowRealEstate #BuildWealth #WealthPreservation #EconomicResilience #RealAssets #CompoundGrowth #FinancialFreedom #LegacyWealth #RecessionResistant  CONNECT WITH BRAD:Website: https://www.evergreencap.com LinkedIn: https://www.linkedin.com/in/bradleyjohnson Interested in Mobile Home Parks? Check this out: https://vintage-funds.com    CONNECT WITH US   For more information about investing with AJ and Chris:  ·    Uptown Syndication | https://www.uptownsyndication.com/  ·    LinkedIn | https://www.linkedin.com/company/71673294/admin/   For information on Portland Property Management:  ·    Uptown Properties | http://www.uptownpm.com  ·    Youtube | @UptownProperties     Westside Investors Network  ·    Website | https://www.westsideinvestorsnetwork.com/  ·    Twitter | https://twitter.com/WIN_pdx  ·    Instagram | @westsideinvestorsnetwork  ·    LinkedIn | https://www.linkedin.com/groups/13949165/  ·    Facebook | @WestsideInvestorsNetwork  ·    Tiktok| @WestsideInvestorsNetwork  ·    Youtube | @WestsideInvestorsNetwork  

In this episode, we take a trip in a time machine, five years into the future. 2030 has been set as a deadline for many climate goals, and is a milestone for checking progress towards a low-carbon energy system. Ed Crooks, Amy Myers Jaffe and Melissa Lott imagine themselves five years from now, and look back at how the US energy industry has changed since the “big beautiful bill” was passed. What do they think have been the key headlines from the last half-decade? And how will history judge America's energy bets?The reconciliation bill that was signed into law by President Trump on July 4 restricted support for low-carbon energy, especially wind and solar power, and doubled down on fossil fuels. The gang break down the sectors that are most at risk, and assess what the changes to tax credits will mean for project developers in renewables and storage. EVs are another sector that will be hit hard. Amy warns that the end result is likely to be a struggling US auto industry and increased Chinese dominance. Another important change is that geopolitics is playing an increased role in deciding who can claim tax credits and who can't. The new rules on FEOCs – foreign entities of concern – from China, Iran, Russia and North Korea could cause headaches for battery storage developers, in particular.Mitigating the impact of all that are state policies and private sector commitments to invest in clean energy, which will continue to push the industry forward. Will they be enough? Amy Myers Jaffe is Director of the Energy, Climate Justice and Sustainability Lab at NYU. Melissa Lott is a Partner at Microsoft, focusing on energy technology, speaking on the show in a personal capacity.With host Ed Crooks, they assess whether the “big beautiful bill” will result in a lasting setback for clean energy in the US, or just a pause for breathe before the next leap forward.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Floods are the most destructive natural disaster and, thanks to a heating climate, the damages caused by floods are expected to worsen significantly. Flood mitigation of the past, such as levies and dams, has proved inadequate and often counterproductive by mis-allocating precious resources. Tim Palmer argues that it's time to start relocating our built environment out of the places with a high likelihood of flooding. (Encore presentation.) Tim Palmer, Seek Higher Ground: The Natural Solution to Our Urgent Flooding Crisis UC Press, 2024 Photograph credit: Mark Moran The post Mitigating Flooding appeared first on KPFA.

Too many women are being told NO to getting hormone replacement therapy (HRT) for their menopause symptoms in midlife.  But the truth is… the benefits of HRT can WAY outweigh the risks for helping you feel like yourself again. The problem?  The massive knowledge gap in hormonal medicine.   That's why this week, I'm joined by the incredible Dr. Louise Newson, a trailblazing general practitioner and menopause specialist who's transforming the conversation around hormone health.  We're diving into the real risks of not prescribing HRT, why hormones can be a game changer for your symptoms, and the surprising link between menopause, migraines, and inflammation.  Dr. Newson is bringing the science and clarity to the HRT convo, and she's here to help you reclaim your voice—and your hormonal health.  Listen here to set the record straight and start advocating for what you truly deserve! Dr. Louise Newson Dr. Louise Newson is a physician, women's hormone specialist, and member of the UK Government's Menopause Taskforce. She's an award-winning doctor, educator, and author, dedicated to raising awareness of women's health in perimenopause and menopause. Dr Louise studied Medicine and Pathology at The University of Manchester in England and worked in hospital medicine before switching to specialize in General Practice and medical writing. IN THIS EPISODE The revolution of bioidentical hormone replacement therapy  Synthetic vs. bioidentical hormones  Advocating for yourself and addressing the conversation of hormone replacement therapy options with your doctor  Individualizing hormone replacement therapies  Hormones for addressing conditions like migraine  How hormones affect women's long-term health  HRT for mitigating inflammation in the entire body  Lifestyle suggestions and habits to promote hormonal balance  QUOTES “Let's just remind ourselves that hormones are an evidence-based treatment and the guidelines are telling us that it has more benefits than risks for the majority of women. Yet… It's only a minority of women in our countries and other countries that are receiving it.”  “It's harrowing what people are being told by their clinicians. And they often just want advice. They don't always want treatment, or they want to know the treatment options available to them in the future. But they're not getting any answers, and I think this is a great disservice to women.”  “I see a lot in the clinic, women who have seen all sorts of specialists, have all sorts of treatments, but no one's spoken about their hormones.” RESOURCES MENTIONED Dr. Louise Newson's Website Dr. Newson's Instagram Dr. Newson's Podcast Get Dr. Newson's FREE Balance App: Your go-to for Menopause Health  Pre-order my new book: The Perimenopause Revolution HERE!  RELATED EPISODES  #647: Hormone Optimization Therapy (HOT) Isn't Your Mom's HRT + It's One Of The Best Strategies For Longevity with Dr. Amy Killen #648: This Changes Everything: The Perimenopause Revolution Every Woman Needs Now #620: What You Need to Know About Premature Menopause, Perimenopause, HRT and Your Options with Dr. Salome Masghati #605: Breaking the HRT Confusion: The Truth Behind Hormone Replacement Therapy for Perimenopausal Women with Karen Martel

We're back with a particularly spicy Rich Girl Roundup—this time covering the absolute barrage of feedback on the last three episodes ("Student Loans, 50% Save Rates, and Being a Capitalist" with JL Collins, "How to Use Economic Uncertainty to Get Closer to Your Dream Life" with Amanda Holden, and Rich Girl Nation's Ask Me Anything conversation). Plus, a few clips from the Rich Girl Nation launch party. Get your copy of Rich Girl Nation: ⁠https://moneywithkatie.com/rich-girl-nation⁠ Transcripts, show notes, resources, and credits can be found at: https://moneywithkatie.com/monopolies — Money with Katie's mission is to be the intersection where the economic, cultural, and political meet the tactical, practical, personal finance education everyone needs. Learn more about your ad choices. Visit megaphone.fm/adchoices